Galanthamine hydrobromide
| Title | Journal |
|---|---|
| Canagliflozin prevents scopolamine-induced memory impairment in rats: Comparison with galantamine hydrobromide action. | Chemico-biological interactions 20171101 |
| Zebrafish biosensor for toxicant induced muscle hyperactivity. | Scientific reports 20160101 |
| Selective activation of α7 nicotinic acetylcholine receptor by PHA-543613 improves Aβ25-35-mediated cognitive deficits in mice. | Neuroscience 20150709 |
| Cloning and characterization of a norbelladine 4'-O-methyltransferase involved in the biosynthesis of the Alzheimer's drug galanthamine in Narcissus sp. aff. pseudonarcissus. | PloS one 20140101 |
| Simultaneous quantification of Amaryllidaceae alkaloids from Zephyranthes grandiflora by UPLC-DAD/ESI-MS/MS. | Journal of pharmaceutical and biomedical analysis 20121201 |
| Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine. | Bioorganic & medicinal chemistry 20121115 |
| Food-drug interactions: effect of capsaicin on the pharmacokinetics of galantamine in rats. | Xenobiotica; the fate of foreign compounds in biological systems 20121101 |
| Investigation of formulation factors affecting in vitro and in vivo characteristics of a galantamine transdermal system. | International journal of pharmaceutics 20121015 |
| Quantification of galantamine in human plasma by validated liquid chromatography-tandem mass spectrometry using glimepride as an internal standard: application to bioavailability studies in 32 healthy Korean subjects. | Journal of chromatographic science 20121001 |
| Mapping of the interaction sites of galanthamine: a quantitative analysis through pairwise potentials and quantum chemistry. | Journal of computer-aided molecular design 20121001 |
| Galantamine, an acetylcholinesterase inhibitor and positive allosteric modulator of nicotinic acetylcholine receptors, attenuates nicotine taking and seeking in rats. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20120901 |
| Effects of fungicides on galanthamine and metabolite profiles in Narcissus bulbs. | Plant physiology and biochemistry : PPB 20120901 |
| High-performance liquid chromatography with fast-scanning fluorescence detection and multivariate curve resolution for the efficient determination of galantamine and its main metabolites in serum. | Analytica chimica acta 20120831 |
| Acetylcholinesterase-inhibiting activity of salicylanilide N-alkylcarbamates and their molecular docking. | Molecules (Basel, Switzerland) 20120824 |
| Effect on cognition of galanthamine administered for neuromuscular block reversal in octogenarians undergoing cataract surgery. | Anaesthesiology intensive therapy 20120808 |
| Production of galanthamine by Leucojum aestivum shoots grown in different bioreactor systems. | Applied biochemistry and biotechnology 20120801 |
| GC-MS of amaryllidaceous galanthamine-type alkaloids. | Journal of mass spectrometry : JMS 20120801 |
| Two galantamine titration regimens in patients switched from donepezil. | Acta neurologica Scandinavica 20120701 |
| 8-[2-(2-Pentyl-cyclopropylmethyl)-cyclopropyl]-octanoic acid and its diastereomers improve age-related cognitive deterioration. | Lipids 20120701 |
| Galantamine administration in chronic post-stroke aphasia. | Journal of neurology, neurosurgery, and psychiatry 20120701 |
| Galantamine effect on tularemia pathogenesis in a BALB/c mouse model. | Iranian biomedical journal 20120701 |
| Longitudinal changes of fractional anisotropy in Alzheimer's disease patients treated with galantamine: a 12-month randomized, placebo-controlled, double-blinded study. | European archives of psychiatry and clinical neuroscience 20120601 |
| Galantamine-based hybrid molecules with acetylcholinesterase, butyrylcholinesterase and γ-secretase inhibition activities. | Current Alzheimer research 20120601 |
| Galantamine attenuates the heroin seeking behaviors induced by cues after prolonged withdrawal in rats. | Neuropharmacology 20120601 |
| Total synthesis of (-)-galanthamine and (-)-lycoramine via catalytic asymmetric hydrogenation and intramolecular reductive Heck cyclization. | Organic letters 20120601 |
| Mixed-effect circadian rhythm model for human erythrocyte acetylcholinesterase activity--application to the proof of concept of cholinesterase inhibition by acorn extract in healthy subjects with galantamine as positive control. | European journal of clinical pharmacology 20120501 |
| Simultaneous determination of antidementia drugs in human plasma: procedure transfer from HPLC-MS to UPLC-MS/MS. | Journal of pharmaceutical and biomedical analysis 20120501 |
| Which cholinesterase inhibitor is the safest for the heart in elderly patients with Alzheimer's disease? | American journal of Alzheimer's disease and other dementias 20120501 |
| Economic evaluation of treatment options in patients with Alzheimer's disease: a systematic review of cost-effectiveness analyses. | Drugs 20120416 |
| Galantamine (Reminyl) delays cardiac ventricular repolarization and prolongs the QT interval by blocking the HERG current. | European journal of pharmacology 20120415 |
| New pharmacological strategies for treatment of Alzheimer's disease: focus on disease modifying drugs. | British journal of clinical pharmacology 20120401 |
| Acute elevations of brain kynurenic acid impair cognitive flexibility: normalization by the alpha7 positive modulator galantamine. | Psychopharmacology 20120401 |
| Drugs for Alzheimer's disease. | British journal of clinical pharmacology 20120401 |
| Cholinesterase inhibitor adjunctive therapy for cognitive impairment and depressive symptoms in older adults with depression. | The Annals of pharmacotherapy 20120401 |
| Symptomatic and nonamyloid/tau based pharmacologic treatment for Alzheimer disease. | Cold Spring Harbor perspectives in medicine 20120301 |
| Galantamine elicits neuroprotection by inhibiting iNOS, NADPH oxidase and ROS in hippocampal slices stressed with anoxia/reoxygenation. | Neuropharmacology 20120201 |
| [Pharmacological profiles of galantamine: the involvement of muscarinic receptor]. | Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology 20120201 |
| Acetylcholinesterase inhibitors for schizophrenia. | The Cochrane database of systematic reviews 20120118 |
| Alkaloid patterns in Leucojum aestivum shoot culture cultivated at temporary immersion conditions. | Journal of plant physiology 20120115 |
| Effects of cholinergic enhancing drugs on cholinergic transporters in the brain and peripheral blood lymphocytes of spontaneously hypertensive rats. | Current Alzheimer research 20120101 |
| Antioxidant enzymatic activities in Alzheimer's disease: the relationship to acetylcholinesterase inhibitors. | Journal of Alzheimer's disease : JAD 20120101 |
| The economic impact of galantamine vs placebo: an analysis based on functional capacity in a Swedish cohort study. | Journal of medical economics 20120101 |
| The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of Technology Appraisal No. 111): a systematic review and economic model. | Health technology assessment (Winchester, England) 20120101 |
| [New anti-AD drugs--their possibilities and issues]. | Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica 20120101 |
| A novel subject synchronization clinical trial design for Alzheimer's disease. | Journal of Alzheimer's disease : JAD 20120101 |
| A combination of galantamine and memantine modifies cognitive function in subjects with amnestic MCI. | The journal of nutrition, health & aging 20120101 |
| Controlled release reservoir mini tablets approach for controlling the drug release of Galantamine Hydrobromide. | Pharmaceutical development and technology 20120101 |
| Donepezil, but not galantamine, blocks muscarinic receptor-mediated in vitro and in vivo responses. | Synapse (New York, N.Y.) 20111201 |
| Galantamine counteracts development of learning impairment in guinea pigs exposed to the organophosphorus poison soman: clinical significance. | Neurotoxicology 20111201 |
| Acetylcholinesterase inhibitors rapidly activate Trk neurotrophin receptors in the mouse hippocampus. | Neuropharmacology 20111201 |
| Synergistic inhibition of butyrylcholinesterase by galantamine and citalopram. | Biochimica et biophysica acta 20111201 |
| Medicinal plants and dementia therapy: herbal hopes for brain aging? | CNS neuroscience & therapeutics 20111201 |
| [Galantamine]. | Nihon rinsho. Japanese journal of clinical medicine 20111201 |
| Kinetic study of the rearrangement of deuterium-labeled 4'-O-methylnorbelladine in Leucojum aestivum shoot cultures by mass spectrometry. Influence of precursor feeding on amaryllidaceae alkaloid accumulation. | Journal of natural products 20111128 |
| Acetylcholinesterase-inhibiting alkaloids from Zephyranthes concolor. | Molecules (Basel, Switzerland) 20111115 |
| Galantamine and behavior in Alzheimer disease: analysis of four trials. | Acta neurologica Scandinavica 20111101 |
| BCHE and CYP2D6 genetic variation in Alzheimer's disease patients treated with cholinesterase inhibitors. | European journal of clinical pharmacology 20111101 |
| Effects of galantamine in Alzheimer's disease: double-blind withdrawal studies evaluating sustained versus interrupted treatment. | Current Alzheimer research 20111101 |
| Galanthamine plus estradiol treatment enhances cognitive performance in aged ovariectomized rats. | Hormones and behavior 20111101 |
| Effective pharmacological management of Alzheimer's disease. | The American journal of managed care 20111101 |
| The costs of Alzheimer's disease and the value of effective therapies. | The American journal of managed care 20111101 |
| Galantamine rescues lead-impaired synaptic plasticity in rat dentate gyrus. | Toxicology 20111028 |
| Structural features and hydrogen-bond properties of galanthamine and codeine: an experimental and theoretical study. | Chemistry (Weinheim an der Bergstrasse, Germany) 20111004 |
| Development of 2-substituted-N-(naphth-1-ylmethyl) and N-benzhydrylpyrimidin-4-amines as dual cholinesterase and Aβ-aggregation inhibitors: Synthesis and biological evaluation. | Bioorganic & medicinal chemistry letters 20111001 |
| Pharmacological treatment of Alzheimer disease. | Canadian journal of psychiatry. Revue canadienne de psychiatrie 20111001 |
| The effects of galantamine on nicotine withdrawal-induced deficits in contextual fear conditioning in C57BL/6 mice. | Behavioural brain research 20110930 |
| Cholinergic hypofunction impairs memory acquisition possibly through hippocampal Arc and BDNF downregulation. | Hippocampus 20110901 |
| Oral tremor induced by galantamine in rats: a model of the parkinsonian side effects of cholinomimetics used to treat Alzheimer's disease. | Pharmacology, biochemistry, and behavior 20110901 |
| An overview on natural cholinesterase inhibitors--a multi-targeted drug class--and their mass production. | Mini reviews in medicinal chemistry 20110901 |
| Pharmacologists and Alzheimer disease therapy: to boldly go where no scientist has gone before. | Expert opinion on investigational drugs 20110901 |
| Effects of cholinesterase inhibitors on postoperative outcomes of older adults with dementia undergoing hip fracture surgery. | The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20110901 |
| [Pharmacological and clinical profiles of galantamine (Reminyl(®))]. | Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20110901 |
| Asymmetric synthesis of bioactive hydrodibenzofuran alkaloids: (-)-lycoramine, (-)-galanthamine, and (+)-lunarine. | Angewandte Chemie (International ed. in English) 20110822 |
| Alkaloids from Hippeastrum papilio. | Molecules (Basel, Switzerland) 20110818 |
| Cytochrome P450 2D6 phenotyping in an elderly population with dementia and response to galantamine in dementia: a pilot study. | The American journal of geriatric pharmacotherapy 20110801 |
| [Newly approved drugs for Alzheimer disease: effectiveness and limitation]. | Brain and nerve = Shinkei kenkyu no shinpo 20110801 |
| New drugs for Alzheimer's disease in Japan. | Psychiatry and clinical neurosciences 20110801 |
| Galantamine (Reminyl) once daily outcome and satisfaction survey (RODOS) in mild to moderate Alzheimer's disease: a study in a real life population. | Geriatrics & gerontology international 20110701 |
| [Daily functioning in dementia: pharmacological and non-pharmacological interventions demonstrate small effects on heterogeneous scales]. | Psychiatrische Praxis 20110701 |
| [Prescription differences of dementia drugs in urban and rural areas in Germany]. | Psychiatrische Praxis 20110701 |
| Effects of adjunct galantamine to risperidone, or haloperidol, in animal models of antipsychotic activity and extrapyramidal side-effect liability: involvement of the cholinergic muscarinic receptor. | The international journal of neuropsychopharmacology 20110601 |
| Galantamine potentiates the protective effect of rofecoxib and caffeic acid against intrahippocampal Kainic acid-induced cognitive dysfunction in rat. | Brain research bulletin 20110530 |
| Possible role of cholinesterase inhibitors on memory consolidation following hypobaric hypoxia of rats. | The International journal of neuroscience 20110501 |
| Effects of galantamine on cocaine use in chronic cocaine users. | The American journal on addictions 20110501 |
| Stability-indicating study of the anti-Alzheimer's drug galantamine hydrobromide. | Journal of pharmaceutical and biomedical analysis 20110428 |
| Effect of fertilizers on galanthamine and metabolite profiles in Narcissus bulbs by 1H NMR. | Journal of agricultural and food chemistry 20110413 |
| Switching cholinesterase inhibitors in older adults with dementia. | International psychogeriatrics 20110401 |
| Metabolic profiling of 3-nitropropionic acid early-stage Huntington's disease rat model using gas chromatography time-of-flight mass spectrometry. | Journal of proteome research 20110401 |
| Synthesis of (-)-homogalanthamine from naltrexone. | The Journal of organic chemistry 20110401 |
| Design, synthesis and structure-activity relationship (SAR) studies of 2,4-disubstituted pyrimidine derivatives: dual activity as cholinesterase and Aβ-aggregation inhibitors. | Bioorganic & medicinal chemistry 20110401 |
| Pharmaco-genetically guided treatment of recurrent rage outbursts in an adult male with 15q13.3 deletion syndrome. | American journal of medical genetics. Part A 20110401 |
| Bradycardia due to cholinesterase inhibitors: identify adverse effects and take them into account. | Prescrire international 20110401 |
| Prescribing trends in cognition enhancing drugs in Australia. | International psychogeriatrics 20110301 |
| Molecular cloning and characterization of a phenylalanine ammonia-lyase gene (LrPAL) from Lycoris radiata. | Molecular biology reports 20110301 |
| Synapse- and subtype-specific modulation of synaptic transmission by nicotinic acetylcholine receptors in the ventrobasal thalamus. | Neuroscience research 20110301 |
| Pharmacokinetic and pharmacodynamic properties of cholinesterase inhibitors donepezil, tacrine, and galantamine in aged and young Lister hooded rats. | Drug metabolism and disposition: the biological fate of chemicals 20110301 |
| Long-term response to galantamine in relation to short-term efficacy data: pooled analysis in patients with mild to moderate Alzheimer's disease. | Current Alzheimer research 20110301 |
| Beneficial effect of repetitive transcranial magnetic stimulation combined with cognitive training for the treatment of Alzheimer's disease: a proof of concept study. | Journal of neural transmission (Vienna, Austria : 1996) 20110301 |
| Cardio-vascular safety of acetyl cholinesterase inhibitors in patients suffering from Alzheimer's disease; factors that predict poor tolerability. | International journal of geriatric psychiatry 20110301 |
| Development and validation of a GC-MS method for rapid determination of galanthamine in Leucojum aestivum and Narcissus ssp.: a metabolomic approach. | Talanta 20110215 |
| Risk factors for nursing home placement in Alzheimer's disease: a longitudinal study of cognition, ADL, service utilization, and cholinesterase inhibitor treatment. | The Gerontologist 20110201 |
| Galantamine augmentation of long-acting injectable risperidone for cognitive impairments in chronic schizophrenia. | Schizophrenia research 20110201 |
| Binding of huperzine A and galanthamine to acetylcholinesterase, based on ONIOM method. | Nanomedicine : nanotechnology, biology, and medicine 20110201 |
| Involvement of decreased muscarinic receptor function in prepulse inhibition deficits in mice reared in social isolation. | British journal of pharmacology 20110201 |
| Acetylcholinesterase inhibitors partially generalize to nicotine discriminative stimulus effect in rats. | Behavioural pharmacology 20110201 |
| Safety and tolerability of galantamine SA in dementia patients transitioned from donepezil. | The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists 20110201 |
| Galantamine improves sustained attention in chronic cocaine users. | Experimental and clinical psychopharmacology 20110201 |
| Ion mobility spectrometry: a valuable tool for kinetic studies in enzymology. | Analytica chimica acta 20110124 |
| Galanthamine and related alkaloids production by Leucojum aestivum L. shoot culture using a temporary immersion technology. | Applied biochemistry and biotechnology 20110101 |
| Long-term outcome and prediction models of activities of daily living in Alzheimer disease with cholinesterase inhibitor treatment. | Alzheimer disease and associated disorders 20110101 |
| Respiratory myoclonus, a side effect of galantamine. | Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20110101 |
| Long-term effects of galantamine treatment on brain functional activities as measured by PET in Alzheimer's disease patients. | Journal of Alzheimer's disease : JAD 20110101 |
| Alkaloid diversity in Galanthus elwesii and Galanthus nivalis. | Chemistry & biodiversity 20110101 |
| Pharmacological aspects of the acetylcholinesterase inhibitor galantamine. | Journal of pharmacological sciences 20110101 |
| [Cholinesterase blockers in anesthesiology: a replenishment of former arsenal]. | Anesteziologiia i reanimatologiia 20110101 |
| Cessation versus continuation of galantamine treatment after 12 months of therapy in patients with Alzheimer's disease: a randomized, double blind, placebo controlled withdrawal trial. | Journal of Alzheimer's disease : JAD 20110101 |
| Galantamine alleviates inflammation and other obesity-associated complications in high-fat diet-fed mice. | Molecular medicine (Cambridge, Mass.) 20110101 |
| Long-term effects of galantamine on cognitive function in Alzheimer's disease: a large-scale international retrospective study. | Journal of Alzheimer's disease : JAD 20110101 |
| [Sleep disorders in patients with dementia in Parkinson's disease]. | Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20110101 |
| [The application of multichannel electrostimulation and nivalin electrophoresis for the rehabilitative treatment of the patient following plastic surgery in the facial region]. | Voprosy kurortologii, fizioterapii, i lechebnoi fizicheskoi kultury 20110101 |
| Galantamine improves olfactory learning in the Ts65Dn mouse model of Down syndrome. | Scientific reports 20110101 |
| [The application of electrical stimulation by bipolar pulsed currents and galanthamine electrophoresis for the rehabilitation of patients with diabetes mellitus]. | Voprosy kurortologii, fizioterapii, i lechebnoi fizicheskoi kultury 20110101 |
| Galantamine-induced amyloid-{beta} clearance mediated via stimulation of microglial nicotinic acetylcholine receptors. | The Journal of biological chemistry 20101217 |
| Localization by site-directed mutagenesis of a galantamine binding site on α7 nicotinic acetylcholine receptor extracellular domain. | Journal of receptor and signal transduction research 20101201 |
| Galantamine ameliorates the impairment of recognition memory in mice repeatedly treated with methamphetamine: involvement of allosteric potentiation of nicotinic acetylcholine receptors and dopaminergic-ERK1/2 systems. | The international journal of neuropsychopharmacology 20101101 |
| Effects of galantamine on β-amyloid release and beta-site cleaving enzyme 1 expression in differentiated human neuroblastoma SH-SY5Y cells. | Experimental gerontology 20101101 |
| Protective effects of galantamine against Abeta-induced PC12 cell apoptosis by preventing mitochondrial dysfunction and endoplasmic reticulum stress. | Neurochemistry international 20101101 |
| Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. | Bioorganic & medicinal chemistry letters 20101101 |
| Indole alkaloids from Ervatamia hainanensis with potent acetylcholinesterase inhibition activities. | Bioorganic & medicinal chemistry letters 20101101 |
| [Beneficial effect of galantamine on sensory information-processing deficits]. | Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20101001 |
| Effects of cholinergic agonists and antagonists under conditions of spleen denervation in rats with endotoxic shock. | Bulletin of experimental biology and medicine 20101001 |
| Evaluation of the effects of galantamine on cardiac function in elderly patients with Alzheimer's disease. | The American journal of geriatric pharmacotherapy 20101001 |
| Drug treatment of Alzheimer's disease patients leads to expression changes in peripheral blood cells. | Alzheimer's & dementia : the journal of the Alzheimer's Association 20100901 |
| Synergistic neuroprotective effect of combined low concentrations of galantamine and melatonin against oxidative stress in SH-SY5Y neuroblastoma cells. | Journal of pineal research 20100901 |
| Pretreatment of Guinea pigs with galantamine prevents immediate and delayed effects of soman on inhibitory synaptic transmission in the hippocampus. | The Journal of pharmacology and experimental therapeutics 20100901 |
| Current treatments for patients with Alzheimer disease. | The Journal of the American Osteopathic Association 20100901 |
| Galantamine inhibits calpain-calcineurin signaling activated by beta-amyloid in human neuroblastoma SH-SY5Y cells. | Neuroscience letters 20100823 |
| Predictors of adherence among Alzheimer's disease patients receiving oral therapy. | Current medical research and opinion 20100801 |
| Discontinuation of cholinesterase inhibitor treatment and determinants thereof in the Netherlands: A retrospective cohort study. | Drugs & aging 20100801 |
| Determination of galanthamine in Bulbus Lycoridis Radiatae by coupling capillary electrophoresis with end-column electrochemiluminescence detection. | Journal of separation science 20100801 |
| Effect of cholinesterase inhibitor galanthamine on circulating tumor necrosis factor alpha in rats with lipopolysaccharide-induced peritonitis. | Chinese medical journal 20100701 |
| Spectrofluorimetry in organized media coupled to second-order multivariate calibration for the determination of galantamine in the presence of uncalibrated interferences. | Talanta 20100630 |
| Young and older good learners have higher levels of brain nicotinic receptor binding. | Neurobiology of aging 20100601 |
| Synthesis of 4-[(diethylamino)methyl]-phenol derivatives as novel cholinesterase inhibitors with selectivity towards butyrylcholinesterase. | Bioorganic & medicinal chemistry letters 20100601 |
| Cholinesterase inhibitors ameliorate spatial learning deficits in rats following hypobaric hypoxia. | Experimental brain research 20100601 |
| The dramatic effects of Galantamine in a patient with early-onset Alzheimer's disease. | Psychiatria Danubina 20100601 |
| [Oral galantamine versus rivastigmine transdermal patch: a descriptive study at a memory clinic in The Netherlands]. | Tijdschrift voor gerontologie en geriatrie 20100601 |
| Semisynthesis and acetylcholinesterase inhibitory activity of stemofoline alkaloids and analogues. | Journal of natural products 20100528 |
| Galantamine inhibits slowly inactivating K+ currents with a dual dose-response relationship in differentiated N1E-115 cells and in CA1 neurones. | European journal of pharmacology 20100525 |
| Total synthesis of (+/-)-galanthamine via a C3-selective Stille coupling and IMDA cycloaddition cascade of 3,5-dibromo-2-pyrone. | Organic letters 20100507 |
| A review of clinical pharmacokinetics and pharmacodynamics of galantamine, a reversible acetylcholinesterase inhibitor for the treatment of Alzheimer's disease, in healthy subjects and patients. | Current clinical pharmacology 20100501 |
| Anticholinesterase duration in the Australian veteran population. | The Australian and New Zealand journal of psychiatry 20100501 |
| Alternative method of oral dosing for rats. | Journal of the American Association for Laboratory Animal Science : JAALAS 20100501 |
| [Variability and trends in dementia drug consumption in Castile-La Mancha (Spain). Estimated prevalence of Alzheimer's disease]. | Neurologia (Barcelona, Spain) 20100501 |
| Super-short solid silicon microneedles for transdermal drug delivery applications. | International journal of pharmaceutics 20100415 |
| Acetylcholinesterase enzyme inhibitory potential of standardized extract of Trigonella foenum graecum L and its constituents. | Phytomedicine : international journal of phytotherapy and phytopharmacology 20100301 |
| Prescribing of drugs for Alzheimer's disease: a South African database analysis. | International psychogeriatrics 20100301 |
| Galantamine for Alzheimer's disease. | Expert opinion on drug metabolism & toxicology 20100301 |
| Reversible acetylcholinesterase inhibitory effect of Tabernaemontana divaricata extract on synaptic transmission in rat CA1 hippocampus. | The Indian journal of medical research 20100301 |
| The ADAS-cog and clinically meaningful change in the VISTA clinical trial of galantamine for Alzheimer's disease. | International journal of geriatric psychiatry 20100201 |
| Increased glutamate in the hippocampus after galantamine treatment for Alzheimer disease. | Progress in neuro-psychopharmacology & biological psychiatry 20100201 |
| [A negative first-line work-up of Raynaud's phenomenon: And what if it were cancer?]. | Journal des maladies vasculaires 20100201 |
| Effects of donepezil, galantamine and rivastigmine in 938 Italian patients with Alzheimer's disease: a prospective, observational study. | CNS drugs 20100201 |
| Iron leads to memory impairment that is associated with a decrease in acetylcholinesterase pathways. | Current neurovascular research 20100201 |
| Galantamine does not cause aggravated orthostatic hypotension in people with Alzheimer's disease. | Journal of the American Geriatrics Society 20100201 |
| Structural and functional neuroprotection in glaucoma: role of galantamine-mediated activation of muscarinic acetylcholine receptors. | Cell death & disease 20100201 |
| Probing Torpedo californica acetylcholinesterase catalytic gorge with two novel bis-functional galanthamine derivatives. | Journal of medicinal chemistry 20100128 |
| Memogain is a galantamine pro-drug having dramatically reduced adverse effects and enhanced efficacy. | Journal of molecular neuroscience : MN 20100101 |
| The astrocyte-derived alpha7 nicotinic receptor antagonist kynurenic acid controls extracellular glutamate levels in the prefrontal cortex. | Journal of molecular neuroscience : MN 20100101 |
| Molecular and cellular actions of galantamine: clinical implications for treatment of organophosphorus poisoning. | Journal of molecular neuroscience : MN 20100101 |
| Analysis of metabolic variation and galanthamine content in Narcissus bulbs by 1H NMR. | Phytochemical analysis : PCA 20100101 |
| Magnetic resonance imaging reveals that galantamine prevents structural brain damage induced by an acute exposure of guinea pigs to soman. | Neurotoxicology 20100101 |
| Promotion effect of norgalanthamine, a component of Crinum asiaticum, on hair growth. | European journal of dermatology : EJD 20100101 |
| Synthesis, spectral characterization and biological evaluation of phosphorylated derivatives of galanthamine. | European journal of medicinal chemistry 20100101 |
| Frontotemporal dementia and pharmacologic interventions. | The Journal of neuropsychiatry and clinical neurosciences 20100101 |
| Galantamine-ER for the treatment of mild-to-moderate Alzheimer's disease. | Clinical interventions in aging 20100101 |
| Cholinergic sensitivity of the developing bullfrog (Rana catesbeiana) does not explain vulnerability to chronic nicotine exposure. | Advances in experimental medicine and biology 20100101 |
| Lower Barthel Index scores predict less prescription of pharmacological therapy in elderly patients with Alzheimer disease. | Dementia and geriatric cognitive disorders 20100101 |
| Important groups of alkaloids derived biosynthetically from phenylalanine and tyrosine. Preface. | The Alkaloids. Chemistry and biology 20100101 |
| Galanthamine from Galanthus and other Amaryllidaceae--chemistry and biology based on traditional use. | The Alkaloids. Chemistry and biology 20100101 |
| Galanthamine production by Leucojum aestivum cultures in vitro. | The Alkaloids. Chemistry and biology 20100101 |
| New prospectives in the delivery of galantamine for elderly patients using the IntelliDrug intraoral device: in vivo animal studies. | Current pharmaceutical design 20100101 |
| Cortical oxygen supply during postural hypotension is further decreased in Alzheimer's disease, but unrelated to cholinesterase-inhibitor use. | Journal of Alzheimer's disease : JAD 20100101 |
| Alkaloid accumulation in different parts and ages of Lycoris chinensis. | Zeitschrift fur Naturforschung. C, Journal of biosciences 20100101 |
| Acetylcholinesterase Inhibitors (AChEI's) for the treatment of visual hallucinations in schizophrenia: a review of the literature. | BMC psychiatry 20100101 |
| Modelling the clinical and economic implications of galantamine in the treatment of mild-to-moderate Alzheimer's disease in Germany. | Journal of medical economics 20100101 |
| Effect of elevated intra-abdominal pressure on the contractile activity and reactivity of smooth muscle tissue from rat gastrointestinal tract to galantamine and drotaverine (No-Spa). | Folia medica 20100101 |
| [Cholinesterase inhibitors for treating dementia. Review]. | Vertex (Buenos Aires, Argentina) 20100101 |
| Dementia. | BMJ clinical evidence 20100101 |
| Acetylcholinesterase inhibition and insulin resistance in late onset Alzheimer's disease. | International psychogeriatrics 20091201 |
| International price comparisons of Alzheimer's drugs: a way to close the affordability gap. | International psychogeriatrics 20091201 |
| Effectiveness of donepezil, rivastigmine, and (+/-)huperzine A in counteracting the acute toxicity of organophosphorus nerve agents: comparison with galantamine. | The Journal of pharmacology and experimental therapeutics 20091201 |
| Metabolic profiling of rat brain and cognitive behavioral tasks: potential complementary strategies in preclinical cognition enhancement research. | Journal of proteome research 20091201 |
| Comparative effectiveness research: an approach to avoiding 'overgeneralized medicine'. | Clinical and translational science 20091201 |
| Concise syntheses of (-)-galanthamine and (+/-)-codeine via intramolecular alkylation of a phenol derivative. | Journal of the American Chemical Society 20091111 |
| Cholinesterase inhibitors and incidence of bradycardia in patients with dementia in the veterans affairs new England healthcare system. | Journal of the American Geriatrics Society 20091101 |
| Alzheimer's disease: Seeing the signs early. | Journal of the American Academy of Nurse Practitioners 20091101 |
| Inhibition of human P-glycoprotein transport and substrate binding using a galantamine dimer. | Biochemical and biophysical research communications 20091030 |
| Effects of galantamine on L-NAME-induced behavioral impairment in Y-maze task in mice. | Neuroscience letters 20091025 |
| Galantamine is a novel post-exposure therapeutic against lethal VX challenge. | Toxicology and applied pharmacology 20091015 |
| Acetylcholinesterase inhibitors enhance cognitive functions in rats following hypobaric hypoxia. | Behavioural brain research 20091012 |
| Are cholinesterase inhibitors effective in the management of the behavioral and psychological symptoms of dementia in Alzheimer's disease? A systematic review of randomized, placebo-controlled trials of donepezil, rivastigmine and galantamine. | International psychogeriatrics 20091001 |
| Trospium and cognition in patients with late onset Alzheimer disease. | The journal of nutrition, health & aging 20091001 |
| Study of acetylcholinesterase inhibitors using CE with contactless conductivity detection. | Electrophoresis 20091001 |
| Case report: combined use of donepezil and galantamine in mixed dementia. | Journal of the American Geriatrics Society 20091001 |
| Galantamine enhancement of long-term potentiation is mediated by calcium/calmodulin-dependent protein kinase II and protein kinase C activation. | Hippocampus 20090901 |
| Misplacing objects in mild to moderate Alzheimer's disease: a descriptive analysis from the VISTA clinical trial. | Journal of neurology, neurosurgery, and psychiatry 20090901 |
| Neuroprotective effect of treatment with galantamine and choline alphoscerate on brain microanatomy in spontaneously hypertensive rats. | Journal of the neurological sciences 20090815 |
| Cholinesterase inhibitory effects of the extracts and compounds of Maclura pomifera (Rafin.) Schneider. | Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20090801 |
| Validation of Abeta1-40 administration into mouse cerebroventricles as an animal model for Alzheimer disease. | Brain research 20090714 |
| Cholinergic deficiency involved in vascular dementia: possible mechanism and strategy of treatment. | Acta pharmacologica Sinica 20090701 |
| Selective cytochrome P450 3A4 inhibitory activity of Amaryllidaceae alkaloids. | Bioorganic & medicinal chemistry letters 20090615 |
| Electroencephalographic effects of galantamine in major depressive disorder. | Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society 20090601 |
| A double-blind, placebo-controlled pilot study of galantamine to improve cognitive dysfunction in minimally symptomatic bipolar disorder. | Journal of clinical psychopharmacology 20090601 |
| Drug-induced sialorrhoea and excessive saliva accumulation. | Prescrire international 20090601 |
| Galantamine inhibits beta-amyloid aggregation and cytotoxicity. | Journal of the neurological sciences 20090515 |
| Treatment of Alzheimer's disease in the long-term-care setting. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20090515 |
| Nefiracetam and galantamine modulation of excitatory and inhibitory synaptic transmission via stimulation of neuronal nicotinic acetylcholine receptors in rat cortical neurons. | Neuroscience 20090505 |
| Treatment with galantamine and time to nursing home placement in Alzheimer's disease patients with and without cerebrovascular disease. | International journal of geriatric psychiatry 20090501 |
| Decreased activation along the dorsal visual pathway after a 3-month treatment with galantamine in mild Alzheimer disease: a functional magnetic resonance imaging study. | Journal of clinical psychopharmacology 20090401 |
| Two-dimensional turbulent flow chromatography coupled on-line to liquid chromatography-mass spectrometry for solution-based ligand screening against multiple proteins. | Journal of chromatography. A 20090320 |
| Effect of R3487/MEM3454, a novel nicotinic alpha7 receptor partial agonist and 5-HT3 antagonist on sustained attention in rats. | Progress in neuro-psychopharmacology & biological psychiatry 20090317 |
| Acteylcholinesterase inhibitor rivastigmine enhances cellular defenses in neuronal and macrophage-like cell lines. | Translational research : the journal of laboratory and clinical medicine 20090301 |
| Roles of nicotinic receptors in acetylcholinesterase inhibitor-induced neuroprotection and nicotinic receptor up-regulation. | Biological & pharmaceutical bulletin 20090301 |
| Nicotinic receptor-mediated neuroprotection in neurodegenerative disease models. | Biological & pharmaceutical bulletin 20090301 |
| An unusual case of nightmares with galantamine. | Journal of the American Geriatrics Society 20090301 |
| Characteristic effects of anti-dementia drugs on rat sleep patterns. | Journal of pharmacological sciences 20090301 |
| Bullous pemphigoid precipitated by galantamine hydrobromide. | Cutis 20090301 |
| Alkaloid synthesis and accumulation in Leucojum aestivum in vitro cultures. | Natural product communications 20090301 |
| Safety and tolerability of galantamine in possible Alzheimer's disease with or without cerebrovascular disease and vascular dementia in Thai patients. | Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20090301 |
| Effects of cholinesterase inhibition on brain white matter volume in Alzheimer's disease. | Neuroreport 20090218 |
| Effects of memantine and galantamine given separately or in association, on memory and hippocampal neuronal loss after transient global cerebral ischemia in gerbils. | Brain research 20090213 |
| Pressurized liquid extraction and anticholinesterase activity-based thin-layer chromatography with bioautography of Amaryllidaceae alkaloids. | Analytica chimica acta 20090209 |
| Design, synthesis and evaluation of galanthamine derivatives as acetylcholinesterase inhibitors. | European journal of medicinal chemistry 20090201 |
| Early postnatal maternal deprivation in rats induces memory deficits in adult life that can be reversed by donepezil and galantamine. | International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience 20090201 |
| Cholinergic modulation of the cerebral metabolic response to citalopram in Alzheimer's disease. | Brain : a journal of neurology 20090201 |
| Simultaneous determination of galantamine, rivastigmine and NAP 226-90 in plasma by MEKC and its application in Alzheimer's disease. | Electrophoresis 20090201 |
| Different cholinesterase inhibitor effects on CSF cholinesterases in Alzheimer patients. | Current Alzheimer research 20090201 |
| Adherence to cholinesterase inhibitors in patients with Alzheimer's disease. | Journal of the American Geriatrics Society 20090201 |
| Galantamine protects against oxidative stress induced by amyloid-beta peptide in cortical neurons. | The European journal of neuroscience 20090201 |
| [Effects of anti-dementia drugs on sleep-wake patterns in sleep-disturbed rats]. | Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology 20090201 |
| Galantamine for dementia in people with Down syndrome. | The Cochrane database of systematic reviews 20090121 |
| Analyses of mortality risk in patients with dementia treated with galantamine. | Acta neurologica Scandinavica 20090101 |
| Brain acetylcholinesterase activity controls systemic cytokine levels through the cholinergic anti-inflammatory pathway. | Brain, behavior, and immunity 20090101 |
| A single in vivo application of cholinesterase inhibitors has neuron type-specific effects on nicotinic receptor activity in guinea pig hippocampus. | The Journal of pharmacology and experimental therapeutics 20090101 |
| A double-blind comparison of galantamine hydrobromide ER and placebo in Parkinson disease. | Journal of neurology, neurosurgery, and psychiatry 20090101 |
| Galantamine-induced improvements in cognitive function are not related to alterations in alpha(4)beta (2) nicotinic receptors in early Alzheimer's disease as measured in vivo by 2-[18F]fluoro-A-85380 PET. | Psychopharmacology 20090101 |
| The effects of galantamine on psychopathology in chronic stable schizophrenia. | Clinical neuropharmacology 20090101 |
| [Relation between Pisa syndrome and choline esterase inhibitors in a cohort of Alzheimer's disease patients]. | Presse medicale (Paris, France : 1983) 20090101 |
| The SERAD study of the safety and efficacy of galantamine in severe Alzheimer's disease. | The Lancet. Neurology 20090101 |
| Safety and efficacy of galantamine (Reminyl) in severe Alzheimer's disease (the SERAD study): a randomised, placebo-controlled, double-blind trial. | The Lancet. Neurology 20090101 |
| Memoquin: a multi-target-directed ligand as an innovative therapeutic opportunity for Alzheimer's disease. | Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 20090101 |
| Galantamine improves apomorphine-induced deficits in prepulse inhibition via muscarinic ACh receptors in mice. | British journal of pharmacology 20090101 |
| Inhibitory potency of choline esterase inhibitors on acetylcholine release and choline esterase activity in fresh specimens of human and rat neocortex. | Journal of Alzheimer's disease : JAD 20090101 |
| Carotid intima-media thickness as a predictor of response to cholinesterase inhibitors in Alzheimer's disease: an open-label trial. | CNS drugs 20090101 |
| Early and differential diagnosis of dementia and mild cognitive impairment: design and cohort baseline characteristics of the German Dementia Competence Network. | Dementia and geriatric cognitive disorders 20090101 |
| Optimal dosing of galantamine in patients with mild or moderate Alzheimer's disease: post Hoc analysis of a randomized, double-blind, placebo-controlled trial. | Drugs & aging 20090101 |
| Verbal repetition in people with mild-to-moderate Alzheimer Disease: a descriptive analysis from the VISTA clinical trial. | Alzheimer disease and associated disorders 20090101 |
| Synthesis and characterization of new galanthamine derivatives comprising peptide moiety. | Protein and peptide letters 20090101 |
| Optimized nutrient medium for galanthamine production in Leucojum aestivum L. in vitro shoot system. | Zeitschrift fur Naturforschung. C, Journal of biosciences 20090101 |
| Persistence with cholinesterase inhibitor therapy for dementia: an observational administrative health database study. | Drugs & aging 20090101 |
| [Galantamine (reminyl) in the treatment of severe Alzheimer's disease]. | Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20090101 |
| Current treatments of Alzheimer disease: are main caregivers satisfied with the drug treatments received by their patients? | Dementia and geriatric cognitive disorders 20090101 |
| Galantamine-ER for cognitive dysfunction in bipolar disorder and correlation with hippocampal neuronal viability: a proof-of-concept study. | CNS neuroscience & therapeutics 20090101 |
| Safety and tolerability of donepezil, rivastigmine and galantamine for patients with Alzheimer's disease: systematic review of the 'real-world' evidence. | Dementia and geriatric cognitive disorders 20090101 |
| [The use of reminyl (galantamine) in the treatment of probable vascular dementia]. | Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20090101 |
| [The use of galantamine in Alzheimer's disease associated with vascular dementia (according to the study of T. Erkinjuntti group)]. | Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20090101 |
| Modeling the cost-effectiveness of galantamine for mild to moderately severe Alzheimer's disease in Korea. | Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20090101 |
| Galantamine reduces striatal degeneration in 3-nitropropionic acid model of Huntington's disease. | Neuroscience letters 20081219 |
| Synergistic effect of galantamine on nicotine-induced neuroprotection in hemiparkinsonian rat model. | Neuroscience research 20081201 |
| Galantamine for the treatment of BPSD in Thai patients with possible Alzheimer's disease with or without cerebrovascular disease. | American journal of Alzheimer's disease and other dementias 20081201 |
| Importance of circadian rhythmicity in the cholinergic treatment of Alzheimer's disease: focus on galantamine*. | Current medical research and opinion 20081201 |
| Effects of cholinotropic and cytostatic drugs on the development of Arthus reaction. | Bulletin of experimental biology and medicine 20081201 |
| Evaluation of galantamine transbuccal absorption by reconstituted human oral epithelium and porcine tissue as buccal mucosa models: part I. | European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20081101 |
| Efficacy and safety of galantamine (reminyl) for dementia in patients with Parkinson's disease (an open controlled trial). | Neuroscience and behavioral physiology 20081101 |
| [Bradycardia induced by galantamine]. | Annales francaises d'anesthesie et de reanimation 20081101 |
| Vesicular acetylcholine transporter (VAChT) in the brain of spontaneously hypertensive rats (SHR): effect of treatment with an acetylcholinesterase inhibitor. | Clinical and experimental hypertension (New York, N.Y. : 1993) 20081101 |
| Domino double Michael-Claisen cyclizations: a powerful general tool for introducing quaternary stereocenters at C4 of cyclohexane-1,3-diones and total synthesis of diverse families of sterically congested alkaloids. | The Journal of organic chemistry 20081003 |
| Decreased initiation of usual activities in people with mild-to-moderate Alzheimer's disease: a descriptive analysis from the VISTA clinical trial. | International psychogeriatrics 20081001 |
| Effects of 5-HT6 receptor antagonism and cholinesterase inhibition in models of cognitive impairment in the rat. | British journal of pharmacology 20081001 |
| Effects of cholinesterase inhibitors on rat nicotinic receptor levels in vivo and in vitro. | Journal of neural transmission (Vienna, Austria : 1996) 20081001 |
| Galantamine treatment in Alzheimer's disease with cerebrovascular disease: responder analyses from a randomized, controlled trial (GAL-INT-6). | Journal of psychopharmacology (Oxford, England) 20080901 |
| Adjunctive galantamine, but not donepezil, enhances the antipsychotic-like effect of raclopride in rats. | The international journal of neuropsychopharmacology 20080901 |
| An open-label pilot study of acetylcholinesterase inhibitors to promote functional recovery in elderly cognitively impaired stroke patients. | Cerebrovascular diseases (Basel, Switzerland) 20080901 |
| Spinal p38 MAP kinase regulates peripheral cholinergic outflow. | Arthritis and rheumatism 20080901 |
| [Galantamine]. | Revue de l'infirmiere 20080901 |
| [Galantamine therapy in dementia associated with CADASIL]. | Revista de neurologia 20080901 |
| The effect of Galantamine on sleep quality in Thai Alzheimer's disease patients. | Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20080901 |
| Drug utilization review of cholinesterase inhibitors in Quebec. | The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 20080901 |
| PET imaging of the in vivo brain acetylcholinesterase activity and nicotine binding in galantamine-treated patients with AD. | Neurobiology of aging 20080801 |
| Lack of beneficial galantamine effect for smoking behavior: a double-blind randomized trial in people with schizophrenia. | Schizophrenia research 20080801 |
| The safety and tolerability of galantamine in patients with epilepsy and memory difficulties. | Epilepsy & behavior : E&B 20080801 |
| Effects of galantamine on cognitive deficits in smokers and non-smokers with schizophrenia. | Schizophrenia research 20080801 |
| A nonlinear mixed effects IVIVC model for multi-release drug delivery systems. | Journal of pharmacokinetics and pharmacodynamics 20080801 |
| Extracts and constituents of Leontopodium alpinum enhance cholinergic transmission: brain ACh increasing and memory improving properties. | Biochemical pharmacology 20080715 |
| High-dose galantamine augmentation inferior to placebo on attention, inhibitory control and working memory performance in nonsmokers with schizophrenia. | Schizophrenia research 20080701 |
| Roles of accessory subunits in alpha4beta2(*) nicotinic receptors. | Molecular pharmacology 20080701 |
| Prevalence of cholinesterase inhibitors in subjects with dementia in Europe. | Pharmacoepidemiology and drug safety 20080701 |
| The impact of galantamine on cognition and mood during electroconvulsive therapy: a pilot study. | Journal of psychiatric research 20080601 |
| A double blind, placebo-controlled pilot study of galantamine augmentation of antidepressant treatment in older adults with major depression. | International journal of geriatric psychiatry 20080601 |
| Galantamine as an adjunctive treatment in major depression. | Journal of clinical psychopharmacology 20080601 |
| Hydrogen-bonding properties of galanthamine: an investigation through crystallographic database observations and computational chemistry. | Acta crystallographica. Section B, Structural science 20080601 |
| Galantamine-induced pisa syndrome: memantine as an alternative. | International journal of geriatric psychiatry 20080601 |
| Comparison of cholinesterase inhibitor utilization patterns and associated health care costs in Alzheimer's disease. | Journal of managed care pharmacy : JMCP 20080601 |
| Safety and efficacy of galantamine in subjects with mild cognitive impairment. | Neurology 20080527 |
| Treatment for MCI: is the evidence sufficient? | Neurology 20080527 |
| Dementia medications in palliative care #174. | Journal of palliative medicine 20080501 |
| Galantamine improves gait performance in patients with Alzheimer's disease. | Journal of the American Geriatrics Society 20080501 |
| [Treatment of Alzheimer's disease: status quo and future considerations]. | Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20080501 |
| Diagnosis and treatment of dementia with Lewy bodies. | JAAPA : official journal of the American Academy of Physician Assistants 20080501 |
| AAFP and ACP release guideline on dementia treatment. | American family physician 20080415 |
| For debate: is the evidence for the efficacy of cholinesterase inhibitors in the symptomatic treatment of Alzheimer's disease convincing or not? | International psychogeriatrics 20080401 |
| N-Alkylated galanthamine derivatives: Potent acetylcholinesterase inhibitors from Leucojum aestivum. | Bioorganic & medicinal chemistry letters 20080401 |
| Galantamine and carbon monoxide protect brain microvascular endothelial cells by heme oxygenase-1 induction. | Biochemical and biophysical research communications 20080314 |
| Summaries for patients. Drug treatment for patients with dementia: American College of Physicians and American Academy of Family Physicians recommendations. | Annals of internal medicine 20080304 |
| Current pharmacologic treatment of dementia: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians. | Annals of internal medicine 20080304 |
| Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline. | Annals of internal medicine 20080304 |
| Antioxidative properties of galantamine on neuronal damage induced by hydrogen peroxide in SK-N-SH cells. | Neurotoxicology 20080301 |
| Inhibition of acetylcholinesterase in CSF versus brain assessed by 11C-PMP PET in AD patients treated with galantamine. | Neurobiology of aging 20080201 |
| Omega-3 supplementation in mild to moderate Alzheimer's disease: effects on neuropsychiatric symptoms. | International journal of geriatric psychiatry 20080201 |
| A randomised double-blind placebo-controlled trial of folic acid supplementation of cholinesterase inhibitors in Alzheimer's disease. | International journal of geriatric psychiatry 20080201 |
| Patterns of decline and evidence of subgroups in patients with Alzheimer's disease taking galantamine for up to 48 months. | International journal of geriatric psychiatry 20080201 |
| Effects of CDP-choline and the combination of CDP-choline and galantamine differ in an animal model of schizophrenia: development of a selective alpha7 nicotinic acetylcholine receptor agonist strategy. | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20080201 |
| Acetylcholinesterase inhibitors in assisted living: patterns of use and association with retention. | International journal of geriatric psychiatry 20080201 |
| Galantamine and donepezil differently affect isolation rearing-induced deficits of prepulse inhibition in mice. | Psychopharmacology 20080201 |
| Prolonged QT interval, syncope, and delirium with galantamine. | The Annals of pharmacotherapy 20080201 |
| Economic and clinical benefits of galantamine in the treatment of mild to moderate Alzheimer's disease in a Korean population: a 52-week prospective study. | Journal of Korean medical science 20080201 |
| Pharmacologic management of Alzheimer disease. | The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses 20080201 |
| [Cholinesterase inhibitors in the treatment of dementia--are they useful in clinical practice?]. | Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20080131 |
| [Therapy of cognitive deficits in schizophrenia with acetylcholinesterase inhibitors. A systematic overview]. | Der Nervenarzt 20080101 |
| Galantamine for the treatment of cognitive impairments in people with schizophrenia. | The American journal of psychiatry 20080101 |
| Galantamine in Alzheimer's disease. | Expert review of neurotherapeutics 20080101 |
| Galantamine in frontotemporal dementia and primary progressive aphasia. | Dementia and geriatric cognitive disorders 20080101 |
| First administration of cytidine diphosphocholine and galantamine in schizophrenia: a sustained alpha7 nicotinic agonist strategy. | Clinical neuropharmacology 20080101 |
| Effects of galantamine on measures of attention: results from 2 clinical trials in Alzheimer disease patients with comparisons to donepezil. | Alzheimer disease and associated disorders 20080101 |
| Analysis of galanthamine-type alkaloids by capillary gas chromatography-mass spectrometry in plants. | Phytochemical analysis : PCA 20080101 |
| New rapid validated HPTLC method for the determination of galanthamine in Amaryllidaceae plant extracts. | Phytochemical analysis : PCA 20080101 |
| The clinical significance of plasmatic amyloid A{beta}-40 peptide levels in Alzheimer's disease patients treated with galantamine. | American journal of Alzheimer's disease and other dementias 20080101 |
| One-week dose titration of extended release galantamine in patients with Alzheimer's disease. | Alzheimer's & dementia : the journal of the Alzheimer's Association 20080101 |
| Review of issue: studies on veterans, a useful pain scale, and plasma amyloid levels as a predictor of response to medications. | American journal of Alzheimer's disease and other dementias 20080101 |
| [Combined use of reminyl (galanthamine) and ovestin (oestradiol) for the treatment of cognitive disorders in women with hypoestrogenic syndrome]. | Eksperimental'naia i klinicheskaia farmakologiia 20080101 |
| Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer's disease: a systematic review and meta-analysis. | Clinical interventions in aging 20080101 |
| Combined models for data from in vitro-in vivo correlation experiments. | Journal of biopharmaceutical statistics 20080101 |
| Intranasal administration of acetylcholinesterase inhibitors. | BMC neuroscience 20080101 |
| Electrically enhanced and controlled drug delivery through buccal mucosa. | Acta poloniae pharmaceutica 20080101 |
| Discontinuing Alzheimer's disease drug therapy: why, when, and how. | Director (Cincinnati, Ohio) 20080101 |
| Influence of galantamine on vasomotor reactivity in Alzheimer's disease and vascular dementia due to cerebral microangiopathy. | Stroke 20071201 |
| An update on the pharmacology of galantamine. | Expert opinion on investigational drugs 20071201 |
| Risperidone, olanzapine and quetiapine in the treatment of behavioral and psychological symptoms in patients with Alzheimer's disease: preliminary findings from a naturalistic, retrospective study. | Psychiatry and clinical neurosciences 20071201 |
| Suzuki-Miyaura and Stille reactions as key steps in the synthesis of diversely functionalized Amaryllidaceae alkaloid analogs bearing a 5,6,7,8-tetrahydrobenzo[c,e]azocine skeleton. | Combinatorial chemistry & high throughput screening 20071101 |
| Weight-loss associated with anti-dementia drugs in a patient with Parkinson's disease. | Movement disorders : official journal of the Movement Disorder Society 20071015 |
| Baseline predictors of rates of hippocampal atrophy in mild cognitive impairment. | Neurology 20071009 |
| Impairments in trace EB conditioning by knife-cut lesions to the fornix in rabbits: reversal by galantamine. | Neurobiology of learning and memory 20071001 |
| Evaluation of centrally acting cholinesterase inhibitor exposures in adults. | The Annals of pharmacotherapy 20071001 |
| Cholinesterase inhibitors: tremor and exacerbation of Parkinson's disease. | Prescrire international 20071001 |
| Diagnosis and management of vascular cognitive impairment. | Current atherosclerosis reports 20071001 |
| [The localization of galanthamine in vegetative organ of Lycoris aurea Herb]. | Fen zi xi bao sheng wu xue bao = Journal of molecular cell biology 20071001 |
| [Are anti-dementia drugs worthwhile?]. | MMW Fortschritte der Medizin 20070913 |
| Cholinesterase inhibitors in dementia with Lewy bodies: a comparative analysis. | International journal of geriatric psychiatry 20070901 |
| Synergistic effect of combined treatment with risperidone and galantamine on phencyclidine-induced impairment of latent visuospatial learning and memory: Role of nAChR activation-dependent increase of dopamine D1 receptor-mediated neurotransmission. | Neuropharmacology 20070901 |
| Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials. | The Lancet. Neurology 20070901 |
| NICE judgement leaves behind a nasty taste. | Nursing older people 20070901 |
| The enantioselective synthesis of (-)-lycoramine with the Birch-Cope sequence. | The Journal of organic chemistry 20070831 |
| Effect of galantamine on verbal repetition in AD: a secondary analysis of the VISTA trial. | Neurology 20070821 |
| Galantamine postischemia provides neuroprotection and memory recovery against transient global cerebral ischemia in gerbils. | The Journal of pharmacology and experimental therapeutics 20070801 |
| Galantamine treatment of vascular dementia: a randomized trial. | Neurology 20070731 |
| Regional brain activity after prolonged cholinergic enhancement in early Alzheimer's disease. | Magnetic resonance imaging 20070701 |
| Competitive antagonism between the nicotinic allosteric potentiating ligand galantamine and kynurenic acid at alpha7* nicotinic receptors. | The Journal of pharmacology and experimental therapeutics 20070701 |
| Beyond in vitro data: a review of in vivo evidence regarding the allosteric potentiating effect of galantamine on nicotinic acetylcholine receptors in Alzheimer's neuropathology. | Journal of Alzheimer's disease : JAD 20070701 |
| High-performance liquid chromatographic method with UV photodiode-array, fluorescence and mass spectrometric detection for simultaneous determination of galantamine and its phase I metabolites in biological samples. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070615 |
| Galanthamine and non-competitive inhibitor binding to ACh-binding protein: evidence for a binding site on non-alpha-subunit interfaces of heteromeric neuronal nicotinic receptors. | Journal of molecular biology 20070615 |
| Activation of dopamine D1 receptors enhances cholinergic transmission and social cognition: a parallel dialysis and behavioural study in rats. | The international journal of neuropsychopharmacology 20070601 |
| Preclinical investigation of the functional effects of memantine and memantine combined with galantamine or donepezil. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20070601 |
| The allosteric potentiation of nicotinic acetylcholine receptors by galantamine ameliorates the cognitive dysfunction in beta amyloid25-35 i.c.v.-injected mice: involvement of dopaminergic systems. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20070601 |
| The acetylcholinesterase inhibitor galantamine inhibits d-amphetamine-induced psychotic-like behavior in Cebus monkeys. | The Journal of pharmacology and experimental therapeutics 20070601 |
| Potential ethnic modifiers in the assessment and treatment of Alzheimer's disease: challenges for the future. | International psychogeriatrics 20070601 |
| [Cholinesterase inhibitors and Alzheimer's disease: meta-analysis of the verification of effectiveness, origin and bias of results in published studies]. | Deutsche medizinische Wochenschrift (1946) 20070601 |
| [Galanthamine versus donepezil in the treatment of Alzheimer's disease]. | Revista de neurologia 20070601 |
| Synthesis of 6beta-D-glucosyl and 6-nitroxy (-)-galanthamine derivatives as acetylcholinesterase inhibitors. | Die Pharmazie 20070601 |
| A rabbit model of Alzheimer's disease: valid at neuropathological, cognitive, and therapeutic levels. | Journal of Alzheimer's disease : JAD 20070601 |
| [Acetylcholinesterase inhibitors for dementia--an update]. | MMW Fortschritte der Medizin 20070521 |
| Cholinesterase inhibitors reduce cortical Abeta in dementia with Lewy bodies. | Neurology 20070515 |
| Stereocontrolled synthesis of (-)-galanthamine. | Organic letters 20070510 |
| In vitro formulation optimization of intranasal galantamine leading to enhanced bioavailability and reduced emetic response in vivo. | International journal of pharmaceutics 20070420 |
| Post-ischemic continuous administration of galantamine attenuates cognitive deficits and hippocampal neurons loss after transient global ischemia in gerbils. | Neuroscience letters 20070406 |
| Effect of galantamine on verbal repetition in AD: a secondary analysis of the VISTA trial. | Neurology 20070403 |
| Efficacy of cognitive rehabilitation in patients with mild cognitive impairment treated with cholinesterase inhibitors. | International journal of geriatric psychiatry 20070401 |
| The influence of galantamine on reaction time, attention processes, and performance variability in elderly Alzheimer patients. | Journal of clinical psychopharmacology 20070401 |
| Comparative analysis of mortality in patients with Alzheimer's disease treated with donepezil and galantamine. | Age and ageing 20070301 |
| A 12-week, double-blind, placebo-controlled trial of galantamine adjunctive treatment to conventional antipsychotics for the cognitive impairments in chronic schizophrenia. | International clinical psychopharmacology 20070301 |
| A 2-year open-label study of galantamine therapy in Chinese Alzheimer's disease patients in Hong Kong. | International journal of clinical practice 20070301 |
| Synergistic effect of galantamine with risperidone on impairment of social interaction in phencyclidine-treated mice as a schizophrenic animal model. | Neuropharmacology 20070301 |
| Treatment strategies for the behavioral symptoms of Alzheimer's disease: focus on early pharmacologic intervention. | Pharmacotherapy 20070301 |
| Treatment of tardive dyskinesia with galantamine: a randomized controlled crossover trial. | The Journal of clinical psychiatry 20070301 |
| Pharmacokinetics and bioequivalence studies of galantamine hydrobromide dispersible tablet in healthy male Chinese volunteers. | Drug development and industrial pharmacy 20070301 |
| Galantamine and donepezil attenuate pharmacologically induced deficits in prepulse inhibition in rats. | Neuropharmacology 20070201 |
| Anti-Alzheimer drugs: life-threatening adverse effects. | Prescrire international 20070201 |
| Quantitative determination of galantamine in human plasma by sensitive liquid chromatography-tandem mass spectrometry using loratadine as an internal standard. | Journal of chromatographic science 20070201 |
| Nicotinic component of galantamine in the regulation of amyloid precursor protein processing. | Chemico-biological interactions 20070130 |
| Changes of cholinesterase activities in the plasma and some tissues following administration of L-carnitine and galanthamine to rats. | Neuroscience letters 20070116 |
| Preparation of secolycorines against acetylcholinesterase. | Bioorganic & medicinal chemistry 20070115 |
| Galantamine enhances dopaminergic neurotransmission in vivo via allosteric potentiation of nicotinic acetylcholine receptors. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20070101 |
| Effect of acetylcholinesterase inhibitors on the binding of nicotinic alpha4beta2 receptor PET radiotracer, (18)F-nifene: A measure of acetylcholine competition. | Synapse (New York, N.Y.) 20070101 |
| Effects of statins on cognitive function in patients with Alzheimer's disease in galantamine clinical trials. | Drugs & aging 20070101 |
| Effect of a M1 allosteric modulator on scopolamine-induced amnesia. | Medicinal chemistry (Shariqah (United Arab Emirates)) 20070101 |
| Galantamine and QTc prolongation. | The Journal of clinical psychiatry 20070101 |
| Posttraumatic stress disorder-like symptoms after treatment with acetylcholinesterase inhibitors. | The Journal of neuropsychiatry and clinical neurosciences 20070101 |
| Evaluation of the slopes of cognitive impairment and disability in Alzheimer's disease (AD) patients treated with acetylcholinesterase inhibitors (AChEl). | Archives of gerontology and geriatrics 20070101 |
| Results of galantamine treatment in acute traumatic brain injury. | Psychosomatics 20070101 |
| Brain activation in elderly people with and without dementia: Influences of gender and medication. | The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20070101 |
| Naturalistic treatment of Alzheimer's disease with galantamine: 12-month follow-up from the NATURE study. | CNS drugs 20070101 |
| Efficacy and safety of galantamine in patients with dementia with Lewy bodies: a 24-week open-label study. | Dementia and geriatric cognitive disorders 20070101 |
| Galantamine for Alzheimer's disease and mild cognitive impairment. | Neuroepidemiology 20070101 |
| Galantamine effects on memory, spatial cue utilization, and neurotrophic factors in aged female rats. | Cell transplantation 20070101 |
| [EEG and clinical psychophysiological study of functional changes in the chronic ischemic brain with increased acetylcholinergic activity]. | Fiziologiia cheloveka 20070101 |
| Modelling disease progression in Alzheimer's disease: a review of modelling methods used for cost-effectiveness analysis. | PharmacoEconomics 20070101 |
| [Alzheimer drugs for mild cognitive impairment]. | Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater 20070101 |
| [Criminal clozapine intoxications]. | Anesteziologiia i reanimatologiia 20070101 |
| Drug interactions with cholinesterase inhibitors: an analysis of the French pharmacovigilance database and a comparison of two national drug formularies (Vidal, British National Formulary). | Drug safety 20070101 |
| Recent developments in cholinesterases inhibitors for Alzheimer's disease treatment. | Current medicinal chemistry 20070101 |
| Alpha-lipoic acid as a new treatment option for Alzheimer's disease--a 48 months follow-up analysis. | Journal of neural transmission. Supplementum 20070101 |
| Alkaloid variability in Leucojum aestivum from wild populations. | Zeitschrift fur Naturforschung. C, Journal of biosciences 20070101 |
| [Efficacy and safety of galantamine (reminyl) in the treatment of dementia in patients with Parkinson's disease (open-label controlled trial)]. | Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20070101 |
| In vitro galantamine-memantine co-application: mechanism of beneficial action. | Neuropharmacology 20061201 |
| The anti-amnesic and neuroprotective effects of donepezil against amyloid beta25-35 peptide-induced toxicity in mice involve an interaction with the sigma1 receptor. | British journal of pharmacology 20061201 |
| Biomimetic synthesis of (+/-)-galanthamine and asymmetric synthesis of (-)-galanthamine using remote asymmetric induction. | Chemical & pharmaceutical bulletin 20061201 |
| Effect of galantamine on acetylcholinesterase and butyrylcholinesterase activities in the presence of L-carnitine in rat selected brain and peripheral tissues. | Neuro endocrinology letters 20061201 |
| Galantamine reduces smoking in alcohol-dependent patients: a randomized, placebo-controlled trial. | International journal of clinical pharmacology and therapeutics 20061201 |
| 6-Hydroxy- and 6-methoxy-beta-carbolines as acetyl- and butyrylcholinesterase inhibitors. | Bioorganic & medicinal chemistry letters 20061115 |
| Micellar electrokinetic chromatography-electrospray ionization mass spectrometry for the identification of drug impurities. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20061107 |
| Neuroprotective effects of galanthamine and tacrine against glutamate neurotoxicity. | European journal of pharmacology 20061107 |
| Cognitive dysfunctions in schizophrenia: potential benefits of cholinesterase inhibitor adjunctive therapy. | Journal of psychiatry & neuroscience : JPN 20061101 |
| Blockade of Ca2+ -activated K+ channels by galantamine can also contribute to the potentiation of catecholamine secretion from chromaffin cells. | European journal of pharmacology 20061024 |
| Augmentation of near infrared diffuse reflectance and transmittance spectral data for the development of robust PLSBC models for classifying double blind clinical trial tablets. | Journal of pharmaceutical and biomedical analysis 20061011 |
| [Medical treatment of Alzheimer's disease]. | Ugeskrift for laeger 20061002 |
| [Retrospective comparative analysis of antidementia medication persistence patterns in Spanish Alzheimer's disease patients treated with donepezil, rivastigmine, galantamine and memantine]. | Revista de neurologia 20061001 |
| Use of antidementia agents in vascular dementia: beyond Alzheimer disease. | Mayo Clinic proceedings 20061001 |
| A prospective, open-label trial of galantamine in autistic disorder. | Journal of child and adolescent psychopharmacology 20061001 |
| Galantamine improves cognition in schizophrenic patients stabilized on risperidone. | Biological psychiatry 20060915 |
| Study of PMS777, a new type of acetylcholinesterase inhibitor, in human HepG2 cells. Comparison with tacrine and galanthamine on oxidative stress and mitochondrial impairment. | Toxicology in vitro : an international journal published in association with BIBRA 20060901 |
| Identification and pharmacological profile of a new class of selective nicotinic acetylcholine receptor potentiators. | The Journal of pharmacology and experimental therapeutics 20060901 |
| [Risperidone and cerebrovascular adverse effects in elderly patients with dementia]. | Revista clinica espanola 20060901 |
| Harmless herbs? Think again: merits of a complete medication history. | Journal of the American Medical Directors Association 20060901 |
| Beneficial effects of galantamine on performance in the object recognition task in Swiss mice: deficits induced by scopolamine and by prolonging the retention interval. | Pharmacology, biochemistry, and behavior 20060901 |
| Taspine: bioactivity-guided isolation and molecular ligand-target insight of a potent acetylcholinesterase inhibitor from Magnolia x soulangiana. | Journal of natural products 20060901 |
| Adjuvant galantamine for cognitive dysfunction in a patient with bipolar disorder. | Journal of psychiatric practice 20060901 |
| Effective countermeasure against poisoning by organophosphorus insecticides and nerve agents. | Proceedings of the National Academy of Sciences of the United States of America 20060829 |
| [Advances in Alzheimer's disease treatment]. | La Revue de medecine interne 20060801 |
| [Cholinesterase inhibitor therapy in long term care settings]. | La Revue de medecine interne 20060801 |
| [Mechanisms of neuroprotective effects of therapeutic acetylcholinesterase inhibitors used in treatment of Alzheimer's disease]. | Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20060801 |
| Alzheimer's disease. | Lancet (London, England) 20060729 |
| [Mortality-associated factors in patients with Alzheimer's disease treated with galantamine]. | Medicina clinica 20060708 |
| Galantamine added to antipsychotic treatment in chronic schizophrenia: cognitive improvement? | Schizophrenia research 20060701 |
| Comparative analysis of mortality in patients with Alzheimer's disease treated with donepezil or galantamine. | Age and ageing 20060701 |
| Pharmacology of acetylcholinesterase inhibitors and N-methyl-D-aspartate receptors for combination therapy in the treatment of Alzheimer's disease. | Journal of clinical pharmacology 20060701 |
| Rationale for combination therapy with galantamine and memantine in Alzheimer's disease. | Journal of clinical pharmacology 20060701 |
| Position statement of the American Association for Geriatric Psychiatry regarding principles of care for patients with dementia resulting from Alzheimer disease. | The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20060701 |
| Choline pivaloyl ester strengthened the benefit effects of Tacrine and Galantamine on electroencephalographic and cognitive performances in nucleus basalis magnocellularis-lesioned and aged rats. | Pharmacology, biochemistry, and behavior 20060701 |
| Effects of galantamine and donepezil on active and passive avoidance tests in rats with induced hypoxia. | Journal of pharmacological sciences 20060701 |
| Therapeutic utility of a novel tight junction modulating peptide for enhancing intranasal drug delivery. | Journal of pharmaceutical sciences 20060601 |
| Alzheimer's disease: beware of interactions with cholinesterase inhibitors. | Prescrire international 20060601 |
| Once-daily formulation of galantamine. | Journal of the American Medical Directors Association 20060601 |
| [Pharmacotherapy of a patient with Alzheimer's disease: interactions with the antidementive galantamine]. | Medizinische Monatsschrift fur Pharmazeuten 20060601 |
| Patterns of cholinesterase-inhibitor use in the nursing home setting: a retrospective analysis. | The American journal of geriatric pharmacotherapy 20060601 |
| [Anti-dementia drugs for dementia syndromes--just unkept promises?]. | MMW Fortschritte der Medizin 20060515 |
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. | Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501 |
| Efficacy study of galantamine in possible Alzheimer's disease with or without cerebrovascular disease and vascular dementia in Thai patients: a slow-titration regimen. | International journal of clinical practice 20060501 |
| [Complete atrioventricular block during galantamine therapy]. | Nederlands tijdschrift voor geneeskunde 20060429 |
| Total synthesis of (+/-)-galanthamine. | Organic letters 20060427 |
| An innovative approach to involve patients in measuring treatment effects in drug trials. | CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20060411 |
| Attainment of treatment goals by people with Alzheimer's disease receiving galantamine: a randomized controlled trial. | CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20060411 |
| Clinical trials in mild cognitive impairment: lessons for the future. | Journal of neurology, neurosurgery, and psychiatry 20060401 |
| Effect of subchronic treatment of memantine, galantamine, and nicotine in the brain of Tg2576 (APPswe) transgenic mice. | The Journal of pharmacology and experimental therapeutics 20060401 |
| Accurate product ion mass spectra of galanthamine derivatives. | Journal of mass spectrometry : JMS 20060401 |
| Galantamine treatment of cognitive impairment in bipolar disorder: four cases. | Bipolar disorders 20060401 |
| A double-blind comparison of galantamine hydrogen bromide and placebo in adults with attention-deficit/hyperactivity disorder: a pilot study. | Journal of clinical psychopharmacology 20060401 |
| Antiamnesic effect of combined treatment with galantamine and estradiol in middle-aged ovariectomized female rats. | Bulletin of experimental biology and medicine 20060401 |
| [Complete atrioventricular block during galantamine therapy]. | Nederlands tijdschrift voor geneeskunde 20060311 |
| Galantamine may improve attention and speech in schizophrenia. | Human psychopharmacology 20060301 |
| Time window in cholinomimetic ability to rescue long-term potentiation in neurodegenerating anti-nerve growth factor mice. | Journal of Alzheimer's disease : JAD 20060301 |
| Post hoc comparison of daily rates of nausea and vomiting with once- and twice-daily galantamine from a double-blind, placebo-controlled, parallel-group, 6-month study. | Clinical therapeutics 20060301 |
| Comparison of galantamine and donepezil for effects on nerve growth factor, cholinergic markers, and memory performance in aged rats. | The Journal of pharmacology and experimental therapeutics 20060201 |
| Galantamine for Alzheimer's disease and mild cognitive impairment. | The Cochrane database of systematic reviews 20060125 |
| Galantamine for vascular cognitive impairment. | The Cochrane database of systematic reviews 20060125 |
| Cholinesterase inhibitors for Alzheimer's disease. | The Cochrane database of systematic reviews 20060125 |
| Cognitive evaluation of disease-modifying efficacy of galantamine and memantine in the APP23 model. | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20060101 |
| Galantamine increases excitability of CA1 hippocampal pyramidal neurons. | Neuroscience 20060101 |
| Cholinergic challenge in Alzheimer patients and mild cognitive impairment differentially affects hippocampal activation--a pharmacological fMRI study. | Brain : a journal of neurology 20060101 |
| Effect of the apolipoprotein E epsilon4 allele on the efficacy and tolerability of galantamine in the treatment of Alzheimer's disease. | Dementia and geriatric cognitive disorders 20060101 |
| Inhibition of hippocampal function in mild cognitive impairment: targeting the cholinergic hypothesis. | Neurobiology of aging 20060101 |
| A systematic review of the clinical effectiveness of donepezil, rivastigmine and galantamine on cognition, quality of life and adverse events in Alzheimer's disease. | International journal of geriatric psychiatry 20060101 |
| Galantamine: a cholinergic patch in the treatment of alcoholism: a randomized, placebo-controlled trial. | Psychopharmacology 20060101 |
| Alarming arbitrariness in EU prescription and reimbursement criteria for anti-dementia drugs. | International journal of geriatric psychiatry 20060101 |
| Novel cholinesterase inhibitors as future effective drugs for the treatment of Alzheimer's disease. | Expert opinion on investigational drugs 20060101 |
| Circadian cholinergic rhythms: implications for cholinesterase inhibitor therapy. | Dementia and geriatric cognitive disorders 20060101 |
| Synthesis and pharmacology of galantamine. | Chemical reviews 20060101 |
| Preventing protein secretion with chemical glue. | Nature chemical biology 20060101 |
| The clinical and cost-effectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer's disease. | Health technology assessment (Winchester, England) 20060101 |
| Galantamine-induced QTc prolongation. | The Journal of clinical psychiatry 20060101 |
| Pharmacological and molecular enhancement of learning in aging and Alzheimer's disease. | Journal of physiology, Paris 20060101 |
| [Use of reminyl (galantamine) in the treatment of dementia]. | Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20060101 |
| Neuroprotection in vascular dementia. | Cerebrovascular diseases (Basel, Switzerland) 20060101 |
| Current and emerging pharmacological treatment options for dementia. | Behavioural neurology 20060101 |
| [Observational study on safety, tolerability and effectiveness of galantamine in patients with mild to moderately severe Alzheimer's disease]. | Neurologia (Barcelona, Spain) 20060101 |
| Galantamine extended release. | CNS drugs 20060101 |
| Acetylcholinesterase inhibitors and sleep architecture in patients with Alzheimer's disease. | Drugs & aging 20060101 |
| [Optimizing effect of the combined administration of 8-OH-DPAT and galantamine on depression--anxiety behavior in old rats with dementia of Alzheimer's type]. | Eksperimental'naia i klinicheskaia farmakologiia 20060101 |
| Towards a unifying hypothesis of Alzheimer's disease: cholinergic system linked to plaques, tangles and neuroinflammation. | Current medicinal chemistry 20060101 |
| [Pharmacotherapy for Alzheimer's disease]. | Tijdschrift voor psychiatrie 20060101 |
| Kinetics of 13 new cholinesterase inhibitors. | Zeitschrift fur Naturforschung. C, Journal of biosciences 20060101 |
| Cholinesterase inhibitors in the clinical management of Alzheimer's disease: importance of early and persistent treatment. | The Journal of international medical research 20060101 |
| A naturalistic study of galantamine for Alzheimer's disease. | CNS drugs 20060101 |
| Determination of therapeutics with growth-hormone secretagogue activity in human urine for doping control purposes. | Rapid communications in mass spectrometry : RCM 20060101 |
| Initiation of acetylcholinesterase inhibitors and complications of chronic airways disorders in elderly patients. | Drug safety 20060101 |
| Realistic expectations for treatment success in Alzheimer's disease. | The journal of nutrition, health & aging 20060101 |
| Galantamine extended release in Alzheimer's disease: profile report. | Drugs & aging 20060101 |
| Alzheimer disease and its management: a review. | American journal of therapeutics 20060101 |
| The N-butylcarbamate derivative of galantamine acts as an allosteric potentiating ligand on alpha7 nicotinic receptors in hippocampal neurons: clinical implications for treatment of Alzheimer's disease. | Journal of molecular neuroscience : MN 20060101 |
| Galanthamine, a natural product for the treatment of Alzheimer's disease. | Recent patents on CNS drug discovery 20060101 |
| Up-regulation of nicotinic acetylcholine receptors by central-type acetylcholinesterase inhibitors in rat cortical neurons. | European journal of pharmacology 20051219 |
| Age-related deficits in the retention of memories for cued fear conditioning are reversed by galantamine treatment. | Behavioural brain research 20051207 |
| Differential effect of PMS777, a new type of acetylcholinesterase inhibitor, and galanthamine on oxidative injury induced in human neuroblastoma SK-N-SH cells. | Neuroscience letters 20051202 |
| Cholinesterase inhibitors ameliorate behavioral deficits induced by MK-801 in mice. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20051201 |
| Unequal neuroprotection afforded by the acetylcholinesterase inhibitors galantamine, donepezil, and rivastigmine in SH-SY5Y neuroblastoma cells: role of nicotinic receptors. | The Journal of pharmacology and experimental therapeutics 20051201 |
| A case with cholinesterase inhibitor responsive asymmetric posterior cortical atrophy. | Clinical neurology and neurosurgery 20051201 |
| Nostocarboline: isolation and synthesis of a new cholinesterase inhibitor from Nostoc 78-12A. | Journal of natural products 20051201 |
| Galantamine antiacetylcholinesterase activity in rat brain influenced by L-carnitine. | Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia 20051201 |
| Dementia. | Clinical evidence 20051201 |
| Nicotinic-receptor potentiator drugs, huprine X and galantamine, increase ACh release by blocking AChE activity but not acting on nicotinic receptors. | Brain research 20051109 |
| Behavioral and neuropsychiatric outcomes in Alzheimer's disease. | CNS spectrums 20051101 |
| A case report of paranoid delusion with galantamine use. | Journal of the American Geriatrics Society 20051101 |
| Divergent enantioselective synthesis of (-)-galanthamine and (-)-morphine. | Journal of the American Chemical Society 20051026 |
| Reduction of voluntary ethanol consumption in alcohol-preferring Alko alcohol (AA) rats by desoxypeganine and galanthamine. | European journal of pharmacology 20051017 |
| Adjuvant galantamine to risperidone improves negative and cognitive symptoms in a patient presenting with schizophrenialike psychosis after traumatic brain injury. | Journal of clinical psychopharmacology 20051001 |
| Do MCI criteria in drug trials accurately identify subjects with predementia Alzheimer's disease? | Journal of neurology, neurosurgery, and psychiatry 20051001 |
| Pharmacokinetics of extended-release and immediate-release formulations of galantamine at steady state in healthy volunteers. | Current medical research and opinion 20051001 |
| New anti-Alzheimer drugs from biodiversity: the role of the natural acetylcholinesterase inhibitors. | Mini reviews in medicinal chemistry 20051001 |
| UK government guidance on Alzheimer's drugs postponed. | Drug discovery today 20050901 |
| Early onset effects of galantamine treatment on attention in patients with Alzheimer's disease. | Current medical research and opinion 20050901 |
| [Traditional dementia concepts in transition--must we change our views?]. | Der Nervenarzt 20050901 |
| Galantamine-induced behavioral recovery after sublethal excitotoxic lesions to the rat medial septum. | Behavioural brain research 20050830 |
| Cholinesterase inhibitors for patients with Alzheimer's disease: systematic review of randomised clinical trials. | BMJ (Clinical research ed.) 20050806 |
| Cellular responses to nicotinic receptor activation are decreased after prolonged exposure to galantamine in human neuroblastoma cells. | British journal of pharmacology 20050801 |
| Development of a novel high-concentration galantamine formulation suitable for intranasal delivery. | Journal of pharmaceutical sciences 20050801 |
| Effect of galantamine on the human alpha7 neuronal nicotinic acetylcholine receptor, the Torpedo nicotinic acetylcholine receptor and spontaneous cholinergic synaptic activity. | British journal of pharmacology 20050701 |
| A cohort study of effectiveness of acetylcholinesterase inhibitors in Alzheimer's disease. | European journal of clinical pharmacology 20050701 |
| Cognitive performance in patients with Alzheimer's disease receiving cholinesterase inhibitors for up to 5 years. | International journal of clinical practice 20050701 |
| [Pharmacological therapy in Alzheimer's disease. Current clinical practice in The Netherlands]. | Tijdschrift voor gerontologie en geriatrie 20050701 |
| Predicting drug metabolism--an evaluation of the expert system METEOR. | Chemistry & biodiversity 20050701 |
| Acute effects of physostigmine and galantamine on the binding of [18F]fluoro-A-85380: a PET study in monkeys. | Synapse (New York, N.Y.) 20050615 |
| Symptomatic effect of donepezil, rivastigmine, galantamine and memantine on cognitive deficits in the APP23 model. | Psychopharmacology 20050601 |
| Reduction of caregiver burden in Alzheimer's disease by treatment with galantamine. | CNS spectrums 20050601 |
| Galantamine treatment of problematic behavior in Alzheimer disease: post-hoc analysis of pooled data from three large trials. | The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20050601 |
| [Changing the anticholinesterase in Alzheimer's disease]. | Revista de neurologia 20050601 |
| Galantamine: excess mortality. | Prescrire international 20050601 |
| Stimulation of nicotinic acetylcholine receptors protects motor neurons. | Biochemical and biophysical research communications 20050520 |
| Steady-state pharmacokinetics of galantamine are not affected by addition of memantine in healthy subjects. | Journal of clinical pharmacology 20050501 |
| Switching from donepezil to galantamine: a double-blind study of two wash-out periods. | International journal of geriatric psychiatry 20050501 |
| Metabolic patterns associated with the clinical response to galantamine therapy: a fludeoxyglucose f 18 positron emission tomographic study. | Archives of neurology 20050501 |
| A comparison of donepezil and galantamine in the treatment of cognitive symptoms of Alzheimer's disease: a meta-analysis. | Human psychopharmacology 20050401 |
| Capillary electrophoresis-mass spectrometry in impurity profiling of pharmaceutical products. | Electrophoresis 20050401 |
| [Cost-effectiveness of galantamine in a german context]. | Psychiatrische Praxis 20050401 |
| Actions of tacrine and galanthamine on histamine-N-methyltransferase. | Methods and findings in experimental and clinical pharmacology 20050401 |
| Pharmacokinetic simulation for switching from galantamine immediate-release to extended-release formulation. | Current medical research and opinion 20050401 |
| [Determination of galanthamine in bulb of Lycoris radiata by RP-HPLC]. | Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica 20050401 |
| Cholinesterase inhibitors in the treatment of dementia. | The Journal of the American Osteopathic Association 20050301 |
| Pharmacologic treatment options in Alzheimer's disease: optimizing disease management. | Journal of the American Academy of Nurse Practitioners 20050301 |
| Galantamine activates muscle-type nicotinic acetylcholine receptors without binding to the acetylcholine-binding site. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20050223 |
| Cholinergic drugs potentiate human nicotinic alpha4beta2 acetylcholine receptors by a competitive mechanism. | European journal of pharmacology 20050221 |
| Brain levels and acetylcholinesterase inhibition with galantamine and donepezil in rats, mice, and rabbits. | Brain research 20050208 |
| Regulatory authorities review use of galantamine in mild cognitive impairment. | BMJ (Clinical research ed.) 20050205 |
| Butyrylcholinesterase inhibitory guaianolides from Amberboa ramosa. | Archives of pharmacal research 20050201 |
| Indicators of neuroprotection with galantamine. | Brain research bulletin 20050130 |
| Effect of cholinergic medication, before and after focal photothrombotic ischemic cortical injury, on histological and functional outcome in aged and young adult rats. | Behavioural brain research 20050106 |
| Central acetylcholinesterase inhibitors in the treatment of chronic traumatic brain injury-clinical experience in 111 patients. | Progress in neuro-psychopharmacology & biological psychiatry 20050101 |
| Not all head-to-head trials are created equal: results from an open-label, short-term study seem inconsistent with previous donepezil literature. | International journal of geriatric psychiatry 20050101 |
| Look-alike, sound-alike drug errors with Reminyl and Amaryl. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20050101 |
| Differential efficacy of treatment with acetylcholinesterase inhibitors in patients with mild and moderate Alzheimer's disease over a 6-month period. | Dementia and geriatric cognitive disorders 20050101 |
| [Treatment of dementia]. | Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics 20050101 |
| Cholinesterase inhibitor affects the amyloid precursor protein isoforms in patients with Alzheimer's disease. | Dementia and geriatric cognitive disorders 20050101 |
| The effect of galantamine added to clozapine on cognition of five patients with schizophrenia. | Clinical neuropharmacology 20050101 |
| Galantamine prolonged-release formulation in the treatment of mild to moderate Alzheimer's disease. | Dementia and geriatric cognitive disorders 20050101 |
| Drug therapy of dementia in elderly patients. A review. | Nordic journal of psychiatry 20050101 |
| Effects of galantamine on working memory and global functioning in patients with mild cognitive impairment: a double-blind placebo-controlled study. | American journal of Alzheimer's disease and other dementias 20050101 |
| [Reminyl efficacy in dementia with Levi bodies]. | Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20050101 |
| Effects of galantamine versus donepezil on sleep in patients with mild to moderate Alzheimer disease and their caregivers: a double-blind, head-to-head, randomized pilot study. | Alzheimer disease and associated disorders 20050101 |
| Emergent complications following donepezil switchover to galantamine in three cases of dementia with Lewy bodies. | The Journal of neuropsychiatry and clinical neurosciences 20050101 |
| [Use of acetylcholinesterase inhibitors and memantine in Alzheimer-type dementia]. | Revista espanola de salud publica 20050101 |
| Galantamine modulates nicotinic receptor and blocks Abeta-enhanced glutamate toxicity. | Biochemical and biophysical research communications 20041217 |
| The complex of a bivalent derivative of galanthamine with torpedo acetylcholinesterase displays drastic deformation of the active-site gorge: implications for structure-based drug design. | Journal of the American Chemical Society 20041201 |
| Challenging the cholinergic system in mild cognitive impairment: a pharmacological fMRI study. | NeuroImage 20041201 |
| Adjuvant therapeutic effects of galantamine on apathy in a schizophrenia patient. | The Journal of clinical psychiatry 20041201 |
| Improved production of galanthamine and related alkaloids by methyl jasmonate in Narcissus confusus shoot-clumps. | Planta medica 20041201 |
| Dementia. | Clinical evidence 20041201 |
| Galantamine blocks cloned Kv2.1, but not Kv1.5 potassium channels. | Brain research. Molecular brain research 20041124 |
| Treatment of vascular dementia--evidence from clinical trials with cholinesterase inhibitors. | Journal of the neurological sciences 20041115 |
| Switching from donepezil or rivastigmine to galantamine in clinical practice. | Journal of the American Geriatrics Society 20041101 |
| Mechanisms of action of cognitive enhancers on neuroreceptors. | Biological & pharmaceutical bulletin 20041101 |
| Long-term efficacy and safety of galantamine in patients with mild-to-moderate Alzheimer's disease: multicenter trial. | European journal of neurology 20041101 |
| An open-label, comparative study of rivastigmine, donepezil and galantamine in a real-world setting. | Current medical research and opinion 20041101 |
| Effects of galantamine in patients with mild Alzheimer's disease. | Current medical research and opinion 20041101 |
| Enhancement of purinergic neurotransmission by galantamine and other acetylcholinesterase inhibitors in the rat vas deferens. | European journal of pharmacology 20041025 |
| Galantamine for Alzheimer's disease. | The Cochrane database of systematic reviews 20041018 |
| Different TMS patterns of intracortical inhibition in early onset Alzheimer dementia and frontotemporal dementia. | Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology 20041001 |
| Reversible Pisa syndrome (pleurothotonus) due to the cholinesterase inhibitor galantamine: case report. | Movement disorders : official journal of the Movement Disorder Society 20041001 |
| A prospective, double-blind, community-controlled comparison of three doses of galantamine in the treatment of mild to moderate Alzheimer's disease in a Korean population. | Clinical therapeutics 20041001 |
| In vivo and in vitro study of the influence of the anticholinesterase drug galantamine on motor and evacuative functions of rat gastrointestinal tract. | European journal of pharmacology 20040913 |
| Effect of galantamine hydrobromide in chronic fatigue syndrome: a randomized controlled trial. | JAMA 20040908 |
| Pharmacotherapy of chronic fatigue syndrome: another gallant attempt. | JAMA 20040908 |
| Mechanism of action of galantamine on N-methyl-D-aspartate receptors in rat cortical neurons. | The Journal of pharmacology and experimental therapeutics 20040901 |
| Evidence-based pharmacotherapy of Alzheimer's disease. | The international journal of neuropsychopharmacology 20040901 |
| Cholinergic drugs for Alzheimer's disease enhance in vitro dopamine release. | Molecular pharmacology 20040901 |
| Regulation of nicotinic acetylcholine receptor channel function by acetylcholinesterase inhibitors in rat hippocampal CA1 interneurons. | Molecular pharmacology 20040901 |
| The benefits and risks associated with cholinesterase inhibitor therapy in Alzheimer's disease. | Expert opinion on drug safety 20040901 |
| Effect of subchronic galantamine treatment on neuronal nicotinic and muscarinic receptor subtypes in transgenic mice overexpressing human acetylcholinesterase. | Neuropharmacology 20040901 |
| Galantamine and nicotine have a synergistic effect on inhibition of microglial activation induced by HIV-1 gp120. | Brain research bulletin 20040830 |
| [Drug-cholinesterase-inhibitors persistence patterns in treated patients with dementia of Alzheimer type: retrospective comparative analysis of donepezil, rivastigmine and galantamine]. | Revista de neurologia 20040801 |
| Galantamine and memantine produce different degrees of neuroprotection in rat hippocampal slices subjected to oxygen-glucose deprivation. | Neuroscience letters 20040722 |
| A case study in the treatment of dementia with Lewy bodies. | Acta psychiatrica Scandinavica 20040701 |
| Galantamine maintains ability to perform activities of daily living in patients with Alzheimer's disease. | Journal of the American Geriatrics Society 20040701 |
| Understanding the latest advances in pharmacologic interventions for Alzheimer's disease. | CNS spectrums 20040701 |
| [Galantamine, an acetylcholinesterase inhibitor with various actions]. | Medizinische Monatsschrift fur Pharmazeuten 20040701 |
| Effects of galantamine, a nicotinic allosteric potentiating ligand, on nicotine-induced catecholamine release in hippocampus and nucleus accumbens of rats. | The Journal of pharmacology and experimental therapeutics 20040601 |
| Galanthamine from snowdrop--the development of a modern drug against Alzheimer's disease from local Caucasian knowledge. | Journal of ethnopharmacology 20040601 |
| Effects of galantamine on behavioural and psychological disturbances and caregiver burden in patients with Alzheimer's disease. | Current medical research and opinion 20040601 |
| Review of donepezil, rivastigmine, galantamine and memantine for the treatment of dementia in Alzheimer's disease in adults with Down syndrome: implications for the intellectual disability population. | International journal of geriatric psychiatry 20040601 |
| Effects of galantamine on attention and memory in Alzheimer's disease measured by computerized neuropsychological tests: results of the Brazilian Multi-Center Galantamine Study (GAL-BRA-01). | Arquivos de neuro-psiquiatria 20040601 |
| ApoE genotyping and response to galanthamine in Alzheimer's disease--a real life retrospective study. | Collegium antropologicum 20040601 |
| Dementia. | Clinical evidence 20040601 |
| Total synthesis of (-)-galanthamine by remote asymmetric induction. | Angewandte Chemie (International ed. in English) 20040510 |
| The clinical efficacy and safety of galantamine in the treatment of Alzheimer's disease. | CNS spectrums 20040501 |
| Drug therapy for Alzheimer's disease. | CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20040427 |
| Emerging therapies for vascular dementia and vascular cognitive impairment. | Stroke 20040401 |
| Examination of nighttime sleep-related problems during double-blind, placebo-controlled trials of galantamine in patients with Alzheimer's disease. | Current medical research and opinion 20040401 |
| Reduction of behavioral disturbances and caregiver distress by galantamine in patients with Alzheimer's disease. | The American journal of psychiatry 20040301 |
| Galantamine: use in Alzheimer's disease and related disorders. | Expert review of neurotherapeutics 20040301 |
| The cognitive benefits of galantamine are sustained for at least 36 months: a long-term extension trial. | Archives of neurology 20040201 |
| A 6-month open-label study of the effectiveness and tolerability of galantamine in patients with Alzheimer's disease. | International journal of clinical practice 20040201 |
| Management of patients with Alzheimer's disease plus cerebrovascular disease: 12-month treatment with galantamine. | Dementia and geriatric cognitive disorders 20040101 |
| Potentiation effects of (+/-)huprine X, a new acetylcholinesterase inhibitor, on nicotinic receptors in rat cortical synaptosomes. | Neuropharmacology 20040101 |
| Galantamine prevents apoptosis induced by beta-amyloid and thapsigargin: involvement of nicotinic acetylcholine receptors. | Neuropharmacology 20040101 |
| Pharmacologic treatment expectations in the management of dementia with Lewy bodies. | Dementia and geriatric cognitive disorders 20040101 |
| Efficacy and safety of galantamine in patients with dementia with Lewy bodies: a 12-week interim analysis. | Dementia and geriatric cognitive disorders 20040101 |
| A multinational, randomised, 12-week study comparing the effects of donepezil and galantamine in patients with mild to moderate Alzheimer's disease. | International journal of geriatric psychiatry 20040101 |
| Galantamine facilitates acquisition of hippocampus-dependent trace eyeblink conditioning in aged rabbits. | Learning & memory (Cold Spring Harbor, N.Y.) 20040101 |
| Galantamine facilitates acquisition of a trace-conditioned eyeblink response in healthy, young rabbits. | Learning & memory (Cold Spring Harbor, N.Y.) 20040101 |
| Acetylcholinesterase inhibition in Alzheimer's Disease. | Current pharmaceutical design 20040101 |
| Pharmacokinetics and tissue distribution of galantamine and galantamine-related radioactivity after single intravenous and oral administration in the rat. | Arzneimittel-Forschung 20040101 |
| Treatment of Huntington's disease with galantamine. | International clinical psychopharmacology 20040101 |
| Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy. | Drugs & aging 20040101 |
| [Drug therapy for aged patients with Alzheimer disease]. | Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica 20040101 |
| [The virtual synapse what is its contribution to understanding cholinergic neural transmission?]. | Therapie 20040101 |
| Effectiveness and safety of cholinesterase inhibitors in elderly subjects with Alzheimer's disease: a 'real world' study. | Archives of gerontology and geriatrics. Supplement 20040101 |
| What are the treatment options for patients with severe Alzheimer's disease? | CNS drugs 20040101 |
| The use, benefits, and costs of cholinesterase inhibitors for Alzheimer's dementia in long-term care: are the data relevant and available? | Journal of the American Medical Directors Association 20040101 |
| Wernicke-Korsakoff syndrome and galantamine. | Psychosomatics 20040101 |
| Ginkgo biloba compared with cholinesterase inhibitors in the treatment of dementia: a review based on meta-analyses by the cochrane collaboration. | Dementia and geriatric cognitive disorders 20040101 |
| Metaanalysis of randomized trials of the efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer disease. | The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20040101 |
| Long-term treatment of Alzheimer disease: efficacy and safety of acetylcholinesterase inhibitors. | Alzheimer disease and associated disorders 20040101 |
| Noncognitive symptoms and long-term treatment expectations for Alzheimer disease. | Alzheimer disease and associated disorders 20040101 |
| The needs of the caregiver in the long-term treatment of Alzheimer disease. | Alzheimer disease and associated disorders 20040101 |
| Assessing the health and economic impact of galantamine treatment in patients with Alzheimer's disease in the health care systems of different countries. | Drugs & aging 20040101 |
| Long-term outcomes of galantamine treatment in patients with Alzheimer disease. | The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20040101 |
| Alleviation of multiple abnormalities by galantamine treatment in two patients with dementia with Lewy bodies. | American journal of Alzheimer's disease and other dementias 20040101 |
| Molecular recognition between 4a S/R-galanthamine diastereoisomers and alpha-cyclodextrin. | Journal of molecular modeling 20031201 |
| Galanthamine distribution in Bulgarian Galanthus spp. | Die Pharmazie 20031201 |
| Galanthamine pattern in Narcissus confusus plants. | Planta medica 20031201 |
| A case history illustrating how extended release cholinesterase inhibitors could improve management of Alzheimer's disease. | Journal of Alzheimer's disease : JAD 20031201 |
| Anticholinesterases in Alzheimer's disease: a modest effect on moderately severe disease. | Prescrire international 20031201 |
| The allosteric potentiation of nicotinic acetylcholine receptors by galantamine is transduced into cellular responses in neurons: Ca2+ signals and neurotransmitter release. | Molecular pharmacology 20031101 |
| Long-term safety and cognitive effects of galantamine in the treatment of probable vascular dementia or Alzheimer's disease with cerebrovascular disease. | European journal of neurology 20031101 |
| Editorial comment--How to treat vascular dementia? | Stroke 20031001 |
| Cognitive, psychiatric and motor response to galantamine in Parkinson's disease with dementia. | International journal of geriatric psychiatry 20031001 |
| The effects of galantamine treatment on caregiver time in Alzheimer's disease. | International journal of geriatric psychiatry 20031001 |
| Modulation of MK-801-elicited mouse popping behavior by galantamine is complex and dose-dependent. | Life sciences 20030919 |
| (-)-9-Dehydrogalanthaminium bromide, a new cholinesterase inhibitor, enhances place and object recognition memory in young and old rats. | Neurobiology of learning and memory 20030901 |
| Update on Alzheimer drugs (galantamine). | The neurologist 20030901 |
| Assessment of health economics in Alzheimer's disease (AHEAD): treatment with galantamine in the UK. | International journal of geriatric psychiatry 20030801 |
| Sleep-related outcomes in persons with mild to moderate Alzheimer disease in a placebo-controlled trial of galantamine. | Sleep 20030801 |
| Synthesis and structure-activity relationships of open D-Ring galanthamine analogues. | Bioorganic & medicinal chemistry letters 20030721 |
| [Acetylcholinesterase inhibitors]. | Revue medicale de la Suisse romande 20030701 |
| Development and validation of a liquid chromatographic-tandem mass spectrometric method for the determination of galantamine in human heparinised plasma. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20030615 |
| Galantamine is an allosterically potentiating ligand of neuronal nicotinic but not of muscarinic acetylcholine receptors. | The Journal of pharmacology and experimental therapeutics 20030601 |
| An open-label extension trial of galantamine in patients with probable vascular dementia and mixed dementia. | Clinical therapeutics 20030601 |
| Economic evaluation of galantamine in the treatment of mild to moderate Alzheimer's disease in the United States. | Clinical therapeutics 20030601 |
| Dementia. | Clinical evidence 20030601 |
| The impact of drugs against dementia on cognition in aging and mild cognitive impairment. | Pharmacopsychiatry 20030601 |
| [Current therapy of patients with dementia]. | MMW Fortschritte der Medizin 20030526 |
| Extended lifetime of reagentless detector for multiple inhibitors of acetylcholinesterase. | Biosensors & bioelectronics 20030501 |
| Galantamine population pharmacokinetics in patients with Alzheimer's disease: modeling and simulations. | Journal of clinical pharmacology 20030501 |
| Galantamine. | The Israel Medical Association journal : IMAJ 20030501 |
| The efficacy of galantamine in the treatment of Alzheimer's disease: comparison of patients previously treated with acetylcholinesterase inhibitors to patients with no prior exposure. | International journal of geriatric psychiatry 20030401 |
| Galantamine: a review of its use in Alzheimer's disease and vascular dementia. | International journal of clinical practice 20030401 |
| Sequential designs for phase III clinical trials incorporating treatment selection. | Statistics in medicine 20030315 |
| Galantamine hydrobromide: an agent for Alzheimer's disease. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20030301 |
| Combined treatment with galanthaminium bromide, a new cholinesterase inhibitor, and RS 67333, a partial agonist of 5-HT4 receptors, enhances place and object recognition in young adult and old rats. | Progress in neuro-psychopharmacology & biological psychiatry 20030201 |
| Acetylcholinesterase inhibitors for vascular dementia and Alzheimer's disease combined with cerebrovascular disease. | Stroke 20030201 |
| Galantamine blocks delayed rectifier, but not transient outward potassium current in rat dissociated hippocampal pyramidal neurons. | Neuroscience letters 20030109 |
| Patterns of clinically detectable treatment effects with galantamine: a qualitative analysis. | Dementia and geriatric cognitive disorders 20030101 |
| Plants with traditional uses and activities, relevant to the management of Alzheimer's disease and other cognitive disorders. | Phytotherapy research : PTR 20030101 |
| Galantamine provides sustained benefits in patients with 'advanced moderate' Alzheimer's disease for at least 12 months. | Dementia and geriatric cognitive disorders 20030101 |
| Mecamylamine interactions with galantamine and donepezil: effects on learning, acetylcholinesterase, and nicotinic acetylcholine receptors. | Neuroscience 20030101 |
| [Zoofilia as late complication of Parkinson's disease. Circe drugs and Mercury antidotes]. | Neurologia (Barcelona, Spain) 20030101 |
| Antioxidant properties of galantamine hydrobromide. | Zeitschrift fur Naturforschung. C, Journal of biosciences 20030101 |
| A long-term comparison of galantamine and donepezil in the treatment of Alzheimer's disease. | Drugs & aging 20030101 |
| Pharmacokinetics of galantamine, a cholinesterase inhibitor, in several animal species. | Arzneimittel-Forschung 20030101 |
| Current treatments for Alzheimer's disease: cholinesterase inhibitors. | The Journal of clinical psychiatry 20030101 |
| Galantamine in the treatment of cognitive decline in patients with vascular dementia or Alzheimer's disease with cerebrovascular disease. | CNS drugs 20030101 |
| Galantamine demonstrates efficacy and safety in elderly patients with Alzheimer disease. | Alzheimer disease and associated disorders 20030101 |
| Clinical experience of galantamine in dementia: a series of case reports. | Current medical research and opinion 20030101 |
| Capillary electrophoresis as an orthogonal technique in HPLC method validation. | Journal of capillary electrophoresis and microchip technology 20030101 |
| [Mechanisms of action of Alzheimer medications]. | Duodecim; laaketieteellinen aikakauskirja 20030101 |
| Galantamine vs donepezil in the treatment of Alzheimer's disease. | Drugs & aging 20030101 |
| Clinical pharmacokinetics of galantamine. | Clinical pharmacokinetics 20030101 |
| [Galantamine (reminyl) in the treatment of Alzheimer's disease and vascular dementia]. | Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20030101 |
| Galantamine in the treatment of adult autism: a report of three clinical cases. | International journal of psychiatry in medicine 20030101 |
| Galantamine in the treatment of vascular dementia. | International psychogeriatrics 20030101 |
| Galantamine may be effective in treating autistic disorder. | BMJ (Clinical research ed.) 20021214 |
| [Early diagnosis and treatment of Alzheimer's disease. Implementation in the doctor's office]. | Fortschritte der Medizin. Originalien 20021205 |
| Unconventional ligands and modulators of nicotinic receptors. | Journal of neurobiology 20021201 |
| Pharmacokinetic and safety assessments of galantamine and risperidone after the two drugs are administered alone and together. | Journal of clinical pharmacology 20021201 |
| Treatment options: the latest evidence with galantamine (Reminyl). | Journal of the neurological sciences 20021115 |
| The rationale behind cholinergic drug treatment for dementia related to cerebrovascular disease. | Journal of the neurological sciences 20021115 |
| Use of galantamine to treat vascular dementia. | Lancet (London, England) 20021109 |
| Use of galantamine to treat vascular dementia. | Lancet (London, England) 20021109 |
| Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomized trial. | Current neurology and neuroscience reports 20021101 |
| A novel treatment for patients with Alzheimer's disease and with vascular dementia. | Annals of the New York Academy of Sciences 20021101 |
| Broad therapeutic benefits in patients with probable vascular dementia or Alzheimer's disease with cerebrovascular disease treated with galantamine. | Annals of the New York Academy of Sciences 20021101 |
| [Anti-dementia drugs for Alzheimer disease in present and future]. | Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20021101 |
| A nitric oxide-donating flurbiprofen derivative reduces neuroinflammation without interacting with galantamine in the rat. | European journal of pharmacology 20021025 |
| Acetylcholinesterase inhibitory activity of some Amaryllidaceae alkaloids and Narcissus extracts. | Life sciences 20021011 |
| The impact of journal advertisements on prescribers of cholinesterase inhibitors. | International journal of geriatric psychiatry 20021001 |
| [Galantamine: a novel cholinergic agent for Alzheimer's disease]. | Neurologia (Barcelona, Spain) 20021001 |
| [The role of substantia nigra in the cognitive activity in cats]. | Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova 20021001 |
| Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomized trial. | Current neurology and neuroscience reports 20020901 |
| Galantamine pharmacokinetics, safety, and tolerability profiles are similar in healthy Caucasian and Japanese subjects. | Journal of clinical pharmacology 20020901 |
| Broad therapeutic benefits in patients with probable vascular dementia or Alzheimer's disease with cerebrovascular disease after treatment with galantamine. | European journal of neurology 20020901 |
| Galantamine provides broad benefits in patients with 'advanced moderate' Alzheimer's disease (MMSE < or = 12) for up to six months. | International journal of clinical practice 20020901 |
| Cerebrospinal fluid levels of biomarkers and activity of acetylcholinesterase (AChE) and butyrylcholinesterase in AD patients before and after treatment with different AChE inhibitors. | Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20020901 |
| An efficient enantioselective synthesis of (-)-galanthamine. | Angewandte Chemie (International ed. in English) 20020802 |
| Galantamine for vascular dementia. | The Lancet. Neurology 20020801 |
| Galantamine for treatment-resistant schizophrenia. | The American journal of psychiatry 20020701 |
| Medical treatment of Alzheimer's disease: past, present, and future. | Medicine and health, Rhode Island 20020701 |
| [Nicotinic Receptor, galantamine and Alzheimer disease]. | Revista de neurologia 20020601 |
| The efficacy of cholinesterase inhibitors in treating the behavioural symptoms of dementia. | International journal of clinical practice. Supplement 20020601 |
| The tolerability and safety of cholinesterase inhibitors in the treatment of dementia. | International journal of clinical practice. Supplement 20020601 |
| Galanthamine as bis-functional ligand for the acetylcholinesterase. | Journal of molecular modeling 20020601 |
| [Latest therapies for treating dementia]. | Atencion primaria 20020515 |
| The metabolism and excretion of galantamine in rats, dogs, and humans. | Drug metabolism and disposition: the biological fate of chemicals 20020501 |
| The nicotinic allosteric potentiating ligand galantamine facilitates synaptic transmission in the mammalian central nervous system. | Molecular pharmacology 20020501 |
| Galantamine for vascular dementia: some answers, some questions. | Lancet (London, England) 20020413 |
| Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial. | Lancet (London, England) 20020413 |
| Pharmacokinetics and safety of galantamine in subjects with hepatic impairment and healthy volunteers. | Journal of clinical pharmacology 20020401 |
| Understanding and managing behavioural symptoms in Alzheimer's disease and related dementias: focus on rivastigmine. | Current medical research and opinion 20020101 |
| Galantamine for Alzheimer's disease. | The Cochrane database of systematic reviews 20020101 |
| Assessment of Health Economics in Alzheimer's Disease (AHEAD): treatment with galantamine in Sweden. | PharmacoEconomics 20020101 |
| Economic analysis of galantamine, a cholinesterase inhibitor, in the treatment of patients with mild to moderate Alzheimer's disease in the Netherlands. | Dementia and geriatric cognitive disorders 20020101 |
| [New theory! Galantamine and nicotinic-cholinergic transmission]. | Pharmazie in unserer Zeit 20020101 |
| Galantamine--a novel cholinergic drug with a unique dual mode of action for the treatment of patients with Alzheimer's disease. | CNS drug reviews 20020101 |
| New drugs 2002, part 1. | Nursing 20020101 |
| Galantamine: a pharmacoeconomic review of its use in Alzheimer's disease. | PharmacoEconomics 20020101 |
| Clinical and cost-effectiveness of donepezil, rivastigmine, and galantamine for Alzheimer's disease. A systematic review. | International journal of technology assessment in health care 20020101 |
| Adjuvant galantamine administration improves negative symptoms in a patient with treatment-refractory schizophrenia. | Clinical neuropharmacology 20020101 |
| Nicotinic receptor modulation: advantages for successful Alzheimer's disease therapy. | Journal of neural transmission. Supplementum 20020101 |
| Nicotinic cholinergic modulation: galantamine as a prototype. | CNS drug reviews 20020101 |
| Vascular dementia: galantamine (Reminyl) as an emerging therapeutic option. | Acta neurologica Scandinavica. Supplementum 20020101 |
| Cognitive decline and treatment options for patients with vascular dementia. | Acta neurologica Scandinavica. Supplementum 20020101 |
| Non-cognitive benefits of galantamine (Reminyl) treatment in vascular dementia. | Acta neurologica Scandinavica. Supplementum 20020101 |
| Solid-phase extraction and reversed-phase high-performance liquid chromatography of the five major alkaloids in Narcissus confusus. | Phytochemical analysis : PCA 20020101 |
| A clinical overview of cholinesterase inhibitors in Alzheimer's disease. | International psychogeriatrics 20020101 |
| [Acetylcholinesterase inhibitors--beyond Alzheimer's disease]. | Psychiatria polska 20020101 |
| [Alzheimer dementia. Comparison of the effectiveness of cholinesterase inhibitors and gingko]. | MMW Fortschritte der Medizin 20011213 |
| Unsafe prescription medication switching recommendations. | Clinical therapeutics 20011201 |
| Galantamine: new preparation. The fourth cholinesterase inhibitor for Alzheimer's disease. | Prescrire international 20011201 |
| Current status and new developments with galantamine in the treatment of Alzheimer's disease. | Expert opinion on pharmacotherapy 20011201 |
| [Perspectives for drug treatment in Alzheimer's disease]. | Annales de medecine interne 20011201 |
| Galantamine hydrobromide. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20011115 |
| Effects of a flexible galantamine dose in Alzheimer's disease: a randomised, controlled trial. | Journal of neurology, neurosurgery, and psychiatry 20011101 |
| Galantamine: a new alzheimer drug with a past life. | The Annals of pharmacotherapy 20011101 |
| Assessment of health economics in Alzheimer's disease (AHEAD): galantamine treatment in Canada. | Neurology 20010925 |
| Sleep and the cholinergic rapid eye movement sleep induction test in patients with primary alcohol dependence. | Biological psychiatry 20010901 |
| Galantamine: a randomized, double-blind, dose comparison in patients with Alzheimer's disease. | International journal of geriatric psychiatry 20010901 |
| [Anticholinesterase agents in Alzheimer's disease]. | Revue medicale de Bruxelles 20010901 |
| Modulation of nicotinic receptor activity in the central nervous system: a novel approach to the treatment of Alzheimer disease. | Alzheimer disease and associated disorders 20010801 |
| Maintaining cognitive function in Alzheimer disease: how effective are current treatments? | Alzheimer disease and associated disorders 20010801 |
| Maintaining functional and behavioral abilities in Alzheimer disease. | Alzheimer disease and associated disorders 20010801 |
| Use of biomimetic diversity-oriented synthesis to discover galanthamine-like molecules with biological properties beyond those of the natural product. | Journal of the American Chemical Society 20010711 |
| Use of cholinesterase inhibitors for treatment of Alzheimer disease. | Cleveland Clinic journal of medicine 20010701 |
| Featured CME topic: dementia. Medication update. | Southern medical journal 20010701 |
| Galantamine (reminyl) for Alzheimer's disease. | The Medical letter on drugs and therapeutics 20010625 |
| Meeting the challenges of vascular dementia. Introduction. | International journal of clinical practice. Supplement 20010501 |
| The pharmacological rationale for treating vascular dementia with galantamine (Reminyl). | International journal of clinical practice. Supplement 20010501 |
| FDA approves galantamine for Alzheimer's disease. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20010415 |
| Differential increase in cerebrospinal fluid-acetylcholinesterase after treatment with acetylcholinesterase inhibitors in patients with Alzheimer's disease. | Neuroscience letters 20010316 |
| Galantamine: effect on nicotinic receptor binding, acetylcholinesterase inhibition, and learning. | Proceedings of the National Academy of Sciences of the United States of America 20010213 |
| Three-dimensional structure of a complex of galanthamine (Nivalin) with acetylcholinesterase from Torpedo californica: implications for the design of new anti-Alzheimer drugs. | Proteins 20010201 |
| Allosteric sensitization of nicotinic receptors by galantamine, a new treatment strategy for Alzheimer's disease. | Biological psychiatry 20010201 |
| Galantamine, a cholinesterase inhibitor that allosterically modulates nicotinic receptors: effects on the course of Alzheimer's disease. | Biological psychiatry 20010201 |
| APOE genotype: no influence on galantamine treatment efficacy nor on rate of decline in Alzheimer's disease. | Dementia and geriatric cognitive disorders 20010101 |
| Clinical and cost-effectiveness of donepezil, rivastigmine and galantamine for Alzheimer's disease: a rapid and systematic review. | Health technology assessment (Winchester, England) 20010101 |
| Galantamine for Alzheimer's disease. | The Cochrane database of systematic reviews 20010101 |
| Therapeutic continuity in Alzheimer's disease: switching patients to galantamine. Introduction. | Clinical therapeutics 20010101 |
| Pharmacokinetic profiles of current therapies for Alzheimer's disease: implications for switching to galantamine. | Clinical therapeutics 20010101 |
| Effects of washout and dose-escalation periods on the efficacy, safety, and tolerability of galantamine in patients previously treated with donepezil: ongoing clinical trials. | Clinical therapeutics 20010101 |
| Switching previous therapies for Alzheimer's disease to galantamine. | Clinical therapeutics 20010101 |
| Therapeutic continuity in Alzheimer's disease: switching patients to galantamine. Panel discussion: recommendations for prescribers. | Clinical therapeutics 20010101 |
| Pharmacokinetic rationale for switching from donepezil to galantamine. | Clinical therapeutics 20010101 |
| Galantamine introduced in Europe. | American journal of Alzheimer's disease and other dementias 20010101 |
| Accurate prediction of the bound conformation of galanthamine in the active site of Torpedo californica acetylcholinesterase using molecular docking. | Journal of molecular graphics & modelling 20010101 |
| Newest developments in dementia treatment and prevention. | Geriatric nursing (New York, N.Y.) 20010101 |
| Galantamine for Alzheimer's disease. | The Cochrane database of systematic reviews 20010101 |
| Drugs used for cognitive symptoms of Alzheimer's disease. | Perspectives in psychiatric care 20010101 |
| Galantamine: a review of its use in Alzheimer's disease. | Drugs 20001101 |
| Structure of acetylcholinesterase complexed with (-)-galanthamine at 2.3 A resolution. | FEBS letters 19991217 |
| Effects of four non-cholinergic cognitive enhancers in comparison with tacrine and galanthamine on scopolamine-induced amnesia in rats. | Psychopharmacology 19920101 |
| Galanthamine hydrobromide, a longer acting anticholinesterase drug, in the treatment of the central effects of scopolamine (Hyoscine). | Der Anaesthesist 19771201 |